Modules
Account Risk
145 rows, unmerged
| Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e99f8e9a9892f809cf6c7372c35d7d886e76e5cd8b172d118bc416886065c617 | OPP-e7d76483dd0c743b2fb23c8d428b9cfa5c78adc3e272a4e4694700594a0798ca | SER-52c241c55b3812070fec5bf451164c316954121d1a7f3e7628e272b0f571d39b | Needs Validation | **** | **** | **** | Sequoia Physician Group, PLLC | 8457 | HQ | Cleveland | TN | East | Unknown | Medium | Olympus / Beckman AU | — | — | — | — | — | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $0.00 versus $2987.28; trailing 180-day revenue $2987.28 versus $39374.32; 112 days beyond expected account order date. | 9096.76 | 18193.52 | 27290.28 | 3552.05 | 7104.1 | 10656.14 | 94.14 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-e99f8e9a9892f809cf6c7372c35d7d886e76e5cd8b172d118bc416886065c617 | Customer 8457 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-29112cf73c1fd594424ec5958d9189a5a32c0357a333107985acdf5b02d9816a | OPP-34a0295add8c75dbbb5b06c1360a3bd955203c8f567db6e4a93d21b4973d893d | SER-0165ca837c23b6824a7b54bb462e3186d23f250857f92e43a02b221d8629c93d | Published | **** | **** | **** | Riverside Medical Associates, LLC | 800 | HQ | Columbia | MD | East | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $109.00 versus $1209.00; trailing 180-day revenue $1318.00 versus $7448.90; 22 days beyond expected account order date. | 5182.53 | 10365.05 | 15547.58 | 2633.58 | 5267.16 | 7900.74 | 93.42 | High | False | True | — | CALL | Candidate CAND-29112cf73c1fd594424ec5958d9189a5a32c0357a333107985acdf5b02d9816a | Customer 800 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-68f83bc82c64d5912d7149cc39836c0ef2e66cbff9baa64098acf5d0645de4e6 | OPP-d5a332380b6a1afe29d2c8bf564637de43d7a938ea6c614680a8099e87445031 | SER-4d4d0c63063e2f3718db164ba95ebd63f63bf6e75668c587fbb6bbc938cd7f9b | Needs Validation | **** | **** | **** | Summit Clinical Labs, LLC | 7021 | HQ | Greensboro | NC | East | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $21152.00; trailing 180-day revenue $21152.00 versus $68566.00; 67 days beyond expected account order date. | 11853.5 | 23707 | 35560.5 | 2529.05 | 5058.11 | 7587.16 | 91.07 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-68f83bc82c64d5912d7149cc39836c0ef2e66cbff9baa64098acf5d0645de4e6 | Customer 7021 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | OPP-2925f4da431f0012264f720dc32f1988a9608d416aa44525ad4d041d13877c76 | SER-922694b967080f34b28991f892661eb90308520023057a913d1c2bb1fa16f03f | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | HQ | Bristol | VA | East | Unknown | Medium | Parts Group | — | — | — | — | — | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $750.00 versus $8742.06; trailing 180-day revenue $9492.06 versus $38284.08; 50 days beyond expected account order date. | 7198.01 | 14396.01 | 21594.02 | 2123.37 | 4246.75 | 6370.12 | 90.87 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | Customer 47700 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-259c4d5931ac8a051783900f88c76d7a7e52fc9352be9c7a537a5be6dbaffc7d | OPP-fdfacddb4d38aa403f7abfc57bb68402fe1cadfa448c74c8d02bd0e4de65c10d | SER-e51f8d72206ed567817c6978662f83c904b15cfb67d50344b715008290371182 | Needs Validation | **** | — | **** | Sequoia Health System, LLC | 7777 | HQ | Nepean | ON | — | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $12688.25 versus $48388.00; trailing 180-day revenue $61076.25 versus $97637.90; 30 days beyond expected account order date. | 17849.88 | 35699.75 | 53549.63 | 5578.93 | 11157.85 | 16736.78 | 89.55 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-259c4d5931ac8a051783900f88c76d7a7e52fc9352be9c7a537a5be6dbaffc7d | Customer 7777 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-228d5123ab4138cdc6180fdd0f0210e137b30bedc1d93ea09907a13dc542224d | OPP-e75f729714c28ea56f64a49bb317fc85ae7977a27cd7701df486b641dda42c4b | SER-23527862def2892391a4d7967f231e1a11253448016e6e926ded4455ae406c6b | Published | **** | **** | **** | Northgate Medical Partners, PLLC | 9333 | Vendor | Dundalk | MD | East | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $2860.00 versus $330.00; trailing 180-day revenue $3190.00 versus $19160.00; -3 days beyond expected account order date. | 3992.5 | 7985 | 11977.5 | 964.42 | 1928.84 | 2893.26 | 85.9 | High | False | False | — | CALL | Candidate CAND-228d5123ab4138cdc6180fdd0f0210e137b30bedc1d93ea09907a13dc542224d | Customer 9333 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8342ff0ef818fc795d071e8c9ae021af9b0b08152c1027e788c8c5b9232a7c82 | OPP-ab55a42e1db705a31a860536d376dc1d1dbdb9e7dcddf4d60434cec8dcc9bf73 | SER-93dc2203e2470bd01c7e198521aac4895e499b6dc8d9e02db67130d1b9016a38 | Published | **** | **** | **** | Lakeside Diagnostic Labs, Corp. | 15496 | HQ | Hazard | KY | East | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $16522.36; 215 days beyond expected account order date. | 8857.1 | 17714.21 | 26571.31 | — | — | — | 83.79 | High | False | True | — | CALL | Candidate CAND-8342ff0ef818fc795d071e8c9ae021af9b0b08152c1027e788c8c5b9232a7c82 | Customer 15496 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9e261e9c5cdcb55433eaa09dba87e9ab5f9cc0cc1318ef0fba439c16a658ac11 | OPP-6faec636ff42c9e691c094c70f84f9cdd17ff374e4b13bd8df38de8af6bf5a35 | SER-295f174f2d2124ffd59863dc6be401fb9acdd93973b2f08151f69aac7207bc67 | Published | **** | **** | **** | Bridgeport Lab Services, PLLC | 41392 | HQ | Charlotte | NC | East | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $125.87; 256 days beyond expected account order date. | 4235.6 | 8471.19 | 12706.79 | 2032.17 | 4064.34 | 6096.52 | 77.55 | Medium | False | False | — | CALL | Candidate CAND-9e261e9c5cdcb55433eaa09dba87e9ab5f9cc0cc1318ef0fba439c16a658ac11 | Customer 41392 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9c32d261d145f036033310edce9480cd178cf756eaed16413c6d5a049de7c734 | OPP-da0d94caedc4d0f1d5a7a4c68b833cedd6f098beb8fadac39d17dab79edc2d77 | SER-e753dad5a335d3704fdb7242c0dd9d0202961893b8d880521d76285689a00cdd | Published | **** | **** | **** | Meridian Lab Services, Inc. | 44111 | HQ | Claymont | DE | East | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $6968.98; 203 days beyond expected account order date. | 1742.25 | 3484.49 | 5226.74 | 557.31 | 1114.62 | 1671.92 | 74.83 | High | False | False | — | ENRICH_CONTACT | Candidate CAND-9c32d261d145f036033310edce9480cd178cf756eaed16413c6d5a049de7c734 | Customer 44111 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a1265a3a6be5560365f222f5a643b49445ae6209af09e3bda896dbbdc5778b72 | OPP-5b8db4ac45d81d75bb9f54c9db2c52541a5dadad94396c5ef650b91e26ce605e | SER-f28e3231e3fb8b4b73f9fecd3e114f6945ab081d7ce5015663e81dec279c8f05 | Needs Validation | **** | **** | **** | Brightwater Health Partners, LLC | 9317 | Vendor | Rockville | MD | East | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $394.16 versus $343.95; trailing 180-day revenue $738.11 versus $2731.25; 30 days beyond expected account order date. | 1601.66 | 3203.33 | 4804.99 | 456.82 | 913.64 | 1370.46 | 71.15 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-a1265a3a6be5560365f222f5a643b49445ae6209af09e3bda896dbbdc5778b72 | Customer 9317 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5ccc1a669e37f394ded852924c177107e813181cb49104559c1a972675756c66 | OPP-6cd17cea18438557f60d5afde18be3422b5703eb6c993f11b3ab9660d6031148 | SER-353b7c3e6764e9e5f6fa65a688e3360b73d75a8a2966e67958a9b05325ca68ba | Published | **** | **** | **** | Riverside Medical Associates, LLC | 800 | Vendor | Columbia | MD | East | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $280.00 versus $384.00; trailing 180-day revenue $664.00 versus $811.25; 12 days beyond expected account order date. | 1709.51 | 3419.02 | 5128.54 | 301.17 | 602.34 | 903.51 | 70.34 | High | False | False | — | CALL | Candidate CAND-5ccc1a669e37f394ded852924c177107e813181cb49104559c1a972675756c66 | Customer 800 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-eb6806ec02c752146530870aae2f350bff4092deff04e1f60b701e83123b8bbf | OPP-3ffe620a2eb7626fb58e1b6f078bd7c8fe4bb772bfdea4f85f0ccbb81edfc97c | SER-ff2084fc78fbc5692872c5077970fc8a323db64c3d1144fb332cf131ca3777cf | Needs Validation | **** | **** | **** | Crestview Health System, PLLC | 6873 | HQ | Utica | KY | East | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $3510.00 versus $685.00; trailing 180-day revenue $4195.00 versus $3936.01; -3 days beyond expected account order date. | 1968.76 | 3937.52 | 5906.28 | 684.76 | 1369.51 | 2054.27 | 69.21 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-eb6806ec02c752146530870aae2f350bff4092deff04e1f60b701e83123b8bbf | Customer 6873 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | OPP-834043c0a0432707e591ec1ea7b469b7ae4773e587cab1d4b8c5ec6409a3ea38 | SER-f0add73e3249c6e8d41ad12fa20ab4ec37e0394a913d2fdede0d8b5ffb89a969 | Needs Validation | **** | **** | **** | Summit Medical Partners, Corp. | 47700 | Vendor | Bristol | VA | East | Unknown | Medium | — | — | — | — | — | — | Materially Delayed Purchasing; 3 independent signals; trailing 90-day revenue $3208.59 versus $5682.83; trailing 180-day revenue $8891.42 versus $12229.35; 33 days beyond expected account order date. | 1528.67 | 3057.34 | 4586.01 | 340.79 | 681.59 | 1022.38 | 65.42 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | Customer 47700 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9eefb6e9ba743309d1eb7b27904227efd596dd4e9fb5b34a88a17d58fc2f5e9d | OPP-2bcdb631a92a5805ab0773994c1a52debb0aa43b19c5851315e4f005509038a7 | SER-e5b0fab5c576bcb4829ec8ff8bda846c40003998fca396a5f799468008a56ad8 | Suppressed by Open Order | **** | **** | **** | Whitmore Diagnostic Labs, Inc. | 7464 | Vendor | Virginia Beach | VA | East | Unknown | Low | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $1978.25; trailing 180-day revenue $1978.25 versus $3711.80; 38 days beyond expected account order date. | 989.13 | 1978.25 | 2967.38 | 169.24 | 338.48 | 507.71 | 64.37 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-9eefb6e9ba743309d1eb7b27904227efd596dd4e9fb5b34a88a17d58fc2f5e9d | Customer 7464 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b31e50958961eee1ecb71c9a916fd1f4bad275a97b40fc455928c20c8f122a52 | OPP-7013436c5c2eaf7a8be9d141aec494fb83b93b483adadba8a26f061ff108278a | SER-55620efb7e437f9391094d345d3c8b00f56ce6f09dcf025b081b320d0bdf8b5e | Suppressed by Open Order | **** | **** | **** | Fairmont Health Alliance, PLLC | 8367 | HQ | Wilmington | NC | East | Unknown | Medium | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $9140.50 versus $11590.95; trailing 180-day revenue $20731.45 versus $23375.69; 7 days beyond expected account order date. | 1510.03 | 3020.05 | 4530.08 | 1095.1 | 2190.19 | 3285.29 | 62.56 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-b31e50958961eee1ecb71c9a916fd1f4bad275a97b40fc455928c20c8f122a52 | Customer 8367 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f9c6a7be64ebf23208af4cf3d6c52c83f69c6a84f70cef52c2a7d9219e9d570a | OPP-e10ede33c98dac9da0cb877dc10d5a46c49ba19160b8f01784694789a2bd6aa2 | SER-e8b7716325fb0c3ad9033895d5c333bac5c3c7daab87c0407b2dd235ce33e549 | Needs Validation | **** | — | **** | Whitmore Care Partners, Corp. | 8254 | HQ | St. George | — | — | Unknown | Medium | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $26864.80 versus $17076.08; trailing 180-day revenue $43940.88 versus $56542.32; -38 days beyond expected account order date. | 3150.36 | 6300.72 | 9451.08 | 699.2 | 1398.4 | 2097.59 | 62.14 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-f9c6a7be64ebf23208af4cf3d6c52c83f69c6a84f70cef52c2a7d9219e9d570a | Customer 8254 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-18554a5e59070bbb6f4801cb308960cba369dd86fb0bce75666be35ca93f347e | OPP-2fda8c6f137e7a73ccfd707193cffbab42163f3747e3d9bf2c131fcde14d106e | SER-5bd0ffccedf2f0b1ca3132f53c9f4f816441c3b0b787befd586e1bfd7ceb3666 | Needs Validation | **** | **** | **** | Maple Pathology Labs, Corp. | 9458 | Vendor | Concord | NC | East | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 420 days beyond expected account order date. | 1025.99 | 2051.98 | 3077.97 | 314.86 | 629.73 | 944.59 | 62 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-18554a5e59070bbb6f4801cb308960cba369dd86fb0bce75666be35ca93f347e | Customer 9458 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-89eec33fb5d7a301c53656bbbc95ebe33ed65fe5f38aeb8e29f5bb2e1702b2ff | OPP-fc1cda4f88871ec27514e7eeed83ee727f97aeeb82178e2392c2f35c24ef8bb1 | SER-fd9e1cec2c48b2bddf68faa102045163714dc297b23c0848aafefb3a15188db4 | Needs Validation | **** | **** | **** | Maple Health Partners, LLC | 8950 | HQ | Charlotte | NC | East | Unknown | Medium | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $1444.81; trailing 180-day revenue $1444.81 versus $0.00; -181 days beyond expected account order date. | 722.4 | 1444.81 | 2167.21 | 355.48 | 710.97 | 1066.45 | 60.89 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-89eec33fb5d7a301c53656bbbc95ebe33ed65fe5f38aeb8e29f5bb2e1702b2ff | Customer 8950 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f0acd9a4b54682990bbe0a7e3049f81cb11d4a0c2e8976fdead7173205c5bdde | OPP-13c86be6eff6543fe4419c2a12df5ef66eaf6046ffa188c2716ad30902aa5838 | SER-10fccc25ee8871833b8a330e74b162983beae993fac3f381b8a137f68a6885e8 | Published | **** | — | **** | Whitmore Diagnostic Labs, PLLC | 9747 | HQ | Guaynabo | — | — | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $266.71; 205 days beyond expected account order date. | 1102.05 | 2204.09 | 3306.14 | 326.9 | 653.8 | 980.71 | 59.04 | Medium | False | True | — | CALL | Candidate CAND-f0acd9a4b54682990bbe0a7e3049f81cb11d4a0c2e8976fdead7173205c5bdde | Customer 9747 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8d786a14a6441c75695172e7061303220afa59c910e9dfff4f5d309a2d60d19a | OPP-22eb9dd857c227bb86f744220b8189211052af00d4f7187cbe2da2a35058ca8b | SER-7ff7a9c1f24043adfce8b587ec19230568158faf0b147eaae9376d59aeca2116 | Needs Validation | **** | **** | **** | Meridian Diagnostic Group, Inc. | 4313 | Vendor | Memphis | TN | East | Research Institution Operating Instruments | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $427.09; trailing 180-day revenue $427.09 versus $1434.79; 21 days beyond expected account order date. | 251.93 | 503.85 | 755.78 | 71.86 | 143.72 | 215.58 | 54.64 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-8d786a14a6441c75695172e7061303220afa59c910e9dfff4f5d309a2d60d19a | Customer 4313 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d84a75a100b83dff245a6f8a38b6c7e2bba460c13a0bde0c0f03a4298e4f96ed | OPP-d7e0a8782fd88a5aa5767fa906d776c532704eaa069c3e14bc45c8bf6fa35923 | SER-a018dcea39df79f795e5ba7023d8ca3bd83dc81c377713fa4030f5cf5244de3b | Needs Validation | **** | **** | **** | Summit Clinical Partners, LLC | 44635 | HQ | Louisville | KY | East | Physician-Office Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $1256.41 versus $1976.62; trailing 180-day revenue $3233.03 versus $3261.43; -25 days beyond expected account order date. | 360.11 | 720.21 | 1080.32 | 111.27 | 222.55 | 333.82 | 54.52 | Low | False | True | — | MANAGER_REVIEW | Candidate CAND-d84a75a100b83dff245a6f8a38b6c7e2bba460c13a0bde0c0f03a4298e4f96ed | Customer 44635 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-af0a029ccaafe4d4140f6730f8f020c7e70b3f8fb2cc6453daaa6e0689b25a73 | OPP-1569273171d892f7b4f4c55a8e801a77589c4da97d4219ba417f39804f436190 | SER-2a366b82d54704b95f14cf6712baa5aa881c6270736d84a9f03f2421dfabe20b | Suppressed by Open Order | **** | **** | **** | Summit Health Collective, LLC | 9768 | HQ | Lexington | KY | East | Unknown | Medium | — | — | — | — | — | — | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $358.77 versus $919.87; trailing 180-day revenue $1278.64 versus $343.86; -3 days beyond expected account order date. | 379.96 | 759.92 | 1139.88 | — | — | — | 52.58 | Low | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-af0a029ccaafe4d4140f6730f8f020c7e70b3f8fb2cc6453daaa6e0689b25a73 | Customer 9768 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b6dd9df5fc4241c4f8aacc73de9b5a2578f40c1b178c111908f7d9694071746a | OPP-f6c08d860d77c25ba3ae89e8835f136ffdc5e8b27c911e251a210783ce61d406 | SER-14b7f629afbe2828293435105719974b7988a80ae228951719efee124938942f | Needs Validation | **** | **** | **** | Summit Clinical Partners, LLC | 44635 | Vendor | Louisville | KY | East | Physician-Office Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $1370.20 versus $2079.67; trailing 180-day revenue $3449.87 versus $2407.15; -4 days beyond expected account order date. | 354.74 | 709.47 | 1064.21 | 85.75 | 171.5 | 257.25 | 51.94 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-b6dd9df5fc4241c4f8aacc73de9b5a2578f40c1b178c111908f7d9694071746a | Customer 44635 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f08bf512630210be0c5f8bb373e61651834e4e7b805dbd66914f4553277730c4 | OPP-ce24be71af440d4451be1ec2c5d90fbc1e7773c2e9a4ab71cabbc72b10d57015 | SER-8853fce1a05333936293c3a68e0a362275a42bfd3bc11d468328abd67bb0bb18 | Published | **** | **** | **** | Elmhurst Physician Group, PLLC | 42572 | Vendor | Franklin | TN | East | End-User Laboratory | High | — | — | — | — | — | — | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $7455.03 versus $7183.78; trailing 180-day revenue $14638.81 versus $17898.18; 8 days beyond expected account order date. | 814.84 | 1629.68 | 2444.53 | 191.54 | 383.08 | 574.62 | 50.65 | Medium | False | False | — | CALL | Candidate CAND-f08bf512630210be0c5f8bb373e61651834e4e7b805dbd66914f4553277730c4 | Customer 42572 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7362ad38b607082c64cf50186a05bf744c34091508de0e87734262f13a539b5a | OPP-921b47ce72e4db1c9179092f7716b3c6888205ae91cb834f984c77ec8274dea8 | SER-0572341be0bd6aab0ee20896409eb380cb0567966059b75ec7c78eeaec35478a | Needs Validation | **** | **** | **** | Bridgeport Lab Services, Inc. | 41316 | HQ | Frankfort | IL | Midwest | Unknown | Medium | Olympus / Beckman AU | — | — | — | — | — | Analyzer Platform Purchasing Loss; 5 independent signals; trailing 90-day revenue $10526.20 versus $33381.98; trailing 180-day revenue $43908.18 versus $98833.18; 0 days beyond expected account order date. | 13731.25 | 27462.5 | 41193.75 | 6084.15 | 12168.29 | 18252.44 | 95.74 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-7362ad38b607082c64cf50186a05bf744c34091508de0e87734262f13a539b5a | Customer 41316 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ee8b9cbdd0e0620db25b5cfd9d73fb0ac068743cd4f1a0ed2af77e9858bf8a5e | OPP-49c719da73ea94ec3bf87ff101f45918058aa2bdc31389c090b061ad4037497c | SER-e9047efa92b5980bb3c9f76e460f1419f6c83fcd3916935ddab765ef2695393b | Published | **** | **** | **** | Copperfield Diagnostics, PLLC | 9363 | Vendor | Plain City | OH | Midwest | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 8 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $76401.35; 210 days beyond expected account order date. | 19100.34 | 38200.68 | 57301.01 | 5618.75 | 11237.51 | 16856.26 | 93.89 | High | False | False | — | CALL | Candidate CAND-ee8b9cbdd0e0620db25b5cfd9d73fb0ac068743cd4f1a0ed2af77e9858bf8a5e | Customer 9363 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | OPP-3bc6d1e73aa671af7ebda7383a507aaab2ddd67fa3e64c2f96c975f87e12624a | SER-8f16eea370409d747c558fc4312ee190c164529876a3954c44a5d55cc0109ed3 | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $11844.24; trailing 180-day revenue $11844.24 versus $41784.22; 130 days beyond expected account order date. | 7484.99 | 14969.99 | 22454.98 | 2072.4 | 4144.81 | 6217.21 | 93.69 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | Customer 7918 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8c93e2f5a239c0e59354eefc5bd49c68d0822ff88ecb737c4b65829201e8f504 | OPP-66ae6699e80839f40f6b62da945115fef292dadf552bbcecb593447113963601 | SER-4e5e4e1d18f83b709761cdf2731e53df4e2eb56a9a26794d50aa9eab0385205e | Suppressed by Open Order | **** | **** | **** | Northgate Clinical Partners, LLC | 35691 | HQ | Naperville | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | — | — | — | — | — | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $0.00 versus $4231.22; trailing 180-day revenue $4231.22 versus $38804.16; 80 days beyond expected account order date. | 8643.23 | 17286.47 | 25929.7 | 4784.01 | 9568.01 | 14352.02 | 91.26 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-8c93e2f5a239c0e59354eefc5bd49c68d0822ff88ecb737c4b65829201e8f504 | Customer 35691 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f8b40ba222e127307586380d52fbb16ffcc68c2867dcf0b5827907bc8ffdd0dc | OPP-ca4543a6bbeaa81db0c72e7235056d25e1af0c499e76c5fd548751c49f8ad489 | SER-c6aa79029387c00b4cf82a64383ac208381cda67d5d276f5250678dcde1ddf07 | Published | **** | **** | **** | Maple Health Collective, LLC | 9818 | HQ | Omaha | NE | Midwest | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 7 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $34431.51; 300 days beyond expected account order date. | 8607.88 | 17215.76 | 25823.63 | 4620.11 | 9240.22 | 13860.32 | 89.9 | High | False | False | — | CALL | Candidate CAND-f8b40ba222e127307586380d52fbb16ffcc68c2867dcf0b5827907bc8ffdd0dc | Customer 9818 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4014df547638c87590915d88b5e2865fcebd24945039cce74c47455614da35a5 | OPP-2b1b46bd8de8c6109676cf1384dd181b1b855cb68906b7013ec37ff88c9d48ac | SER-9df3f762f8829ccaa90f470647b1ed3331f6e11933047f13ab370fe57e5a399e | Needs Validation | **** | **** | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | Oakbrook Terrace | IL | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $4493.42 versus $11463.52; trailing 180-day revenue $15956.94 versus $22416.28; 5 days beyond expected account order date. | 3485.05 | 6970.1 | 10455.15 | 2517.34 | 5034.69 | 7552.03 | 83.4 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-4014df547638c87590915d88b5e2865fcebd24945039cce74c47455614da35a5 | Customer 7676 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c3038b322c37ae3387ac913a1617d8af03c661ae6d6a3ea19282a154ff3377e2 | OPP-2789ca36af769ab91446950154384137f766d344d7148d75bb8fa6c08ec1b848 | SER-453a05caf3b6c441b013002555a8cb1b4b0fbd2fbb8fbb1ce846cadf3be8663c | Published | **** | **** | **** | Meridian Medical Center, Corp. | 10031 | Vendor | Loveland | OH | Midwest | Research Institution Operating Instruments | High | — | Fisher Healthcare | — | — | — | — | Product Family Purchasing Loss; 5 independent signals; trailing 90-day revenue $2067.06 versus $5873.28; trailing 180-day revenue $7940.34 versus $9234.26; 11 days beyond expected account order date. | 1903.11 | 3806.22 | 5709.33 | 491.9 | 983.81 | 1475.71 | 79.28 | High | False | True | — | CALL | Candidate CAND-c3038b322c37ae3387ac913a1617d8af03c661ae6d6a3ea19282a154ff3377e2 | Customer 10031 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e605136bea41549afccefbc67b785bbe3b6d55515c7b4cfbe091ceaa009a34b7 | OPP-aac3a0845741fb5ddd72fb9546361e9198f24697450d73ae4599780d391aafaf | SER-88b14183650eea075e79c07d904bd29503d45e82479392e49b069c9305133149 | Published | **** | **** | **** | Copperfield Diagnostics, PLLC | 9363 | HQ | Plain City | OH | Midwest | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 7 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $10467.93; 208 days beyond expected account order date. | 2791.8 | 5583.61 | 8375.41 | — | — | — | 76.7 | High | False | False | — | CALL | Candidate CAND-e605136bea41549afccefbc67b785bbe3b6d55515c7b4cfbe091ceaa009a34b7 | Customer 9363 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c858f72967f1b80ea0ab46c561100aedcc94e7a026a741114e5f8f53b4ef1fc7 | OPP-8f2df22f2a71282c68d79abd963e864245689b21171023d9c9e2ce767cbff75d | SER-3c38da376f9adc1fa203b7545a647c845144f21e596f189016e667256fa39342 | Published | **** | **** | **** | Copperfield Diagnostics, PLLC | 9363 | Vendor | Plain City | OH | Midwest | End-User Laboratory | High | — | — | — | — | — | — | Account Risk; 1 independent signal; trailing 90-day revenue $26805.27 versus $43240.16; trailing 180-day revenue $70045.43 versus $14170.17; -3 days beyond expected account order date. | 8217.45 | 16434.89 | 24652.34 | 2056.31 | 4112.61 | 6168.92 | 75.98 | Medium | False | True | — | CALL | Candidate CAND-c858f72967f1b80ea0ab46c561100aedcc94e7a026a741114e5f8f53b4ef1fc7 | Customer 9363 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fae275c9c9824dfb5b03299f7ad3d087fbcc42867c3b308db42f1a06fb3f544e | OPP-25baea2f24c39e1bd8e3f686e340aa4edb396a59b9e9153e4ebe65adda940806 | SER-836de20841585e07c296448e284e07355eef90f3b58d1cdfdd7325ff84bbe99d | Needs Validation | **** | **** | **** | Maple Health Alliance, PLLC | 42712 | HQ | Downers Grove | IL | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $676.00 versus $0.00; trailing 180-day revenue $676.00 versus $2258.45; -13 days beyond expected account order date. | 2378.14 | 4756.27 | 7134.41 | 1266.92 | 2533.85 | 3800.77 | 75.18 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-fae275c9c9824dfb5b03299f7ad3d087fbcc42867c3b308db42f1a06fb3f544e | Customer 42712 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d0392f76212dfd783b6e351f694ae29ed630e2a6fb13c8d2fcc30ae171ecde66 | OPP-bb5b120a1cee987b4932b5f76b8826491b48612f757f95f199bfbf134b4c5327 | SER-29e64f325d788084c284fcfe6bea97160b1a1922769f7c2eb67c3a7013733a1d | Published | **** | **** | **** | Whitmore Laboratory Partners, PLLC | 41400 | HQ | Madison Heights | MI | Midwest | Reseller | High | — | — | — | — | — | — | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $11072.02; 179 days beyond expected account order date. | 2768.01 | 5536.01 | 8304.02 | — | — | — | 75.04 | High | False | False | — | CALL | Candidate CAND-d0392f76212dfd783b6e351f694ae29ed630e2a6fb13c8d2fcc30ae171ecde66 | Customer 41400 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c0dc222b766bcbcac3682743d06a85299066b9a09ea93b2874a8544d7fa07eff | OPP-ef3e8df9c19780667bf76156bacac6d96532c4593cae8ecffa9f3211d8186f58 | SER-6f6436668faa73343dfcbbb21b2d08b88d9f0564edbb41e0aa58482c0144c702 | Published | **** | **** | **** | Meridian Medical Center, Corp. | 10031 | HQ | Loveland | OH | Midwest | Research Institution Operating Instruments | High | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $438.29 versus $9014.23; trailing 180-day revenue $9452.52 versus $5786.43; 6 days beyond expected account order date. | 4287.97 | 8575.94 | 12863.91 | — | — | — | 72.44 | High | False | True | — | CALL | Candidate CAND-c0dc222b766bcbcac3682743d06a85299066b9a09ea93b2874a8544d7fa07eff | Customer 10031 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef2420613e7833412c2b80430ddcca5d7b9c38fadee32de0936546bd7ab55db1 | OPP-d090ea208e10dfe9667e2e4469685fdbba01269164fe94eba57f555b54f32894 | SER-47757be37c5e3b53120487440c06746f33565083898b410d4f9d51604a60244c | Published | **** | **** | **** | Ironwood Clinical Group, Inc. | 7169 | HQ | Dearborn | MI | Midwest | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 4 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $2005.00; 148 days beyond expected account order date. | 1179.07 | 2358.14 | 3537.21 | — | — | — | 71.7 | Medium | False | True | — | CALL | Candidate CAND-ef2420613e7833412c2b80430ddcca5d7b9c38fadee32de0936546bd7ab55db1 | Customer 7169 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dc22ebceaf1cbc63b420f962eaf787a5d4f17fe2387432957f7c920f3447b761 | OPP-beb9c4975f8099e3a93af2cdcf92f42c80d81bfc17263bd1b1d43d41038b3431 | SER-b837249f6981926ed27b738c311db36cca74dc9a223812127471a4c9cd2a7b81 | Needs Validation | **** | **** | **** | Maple Health Partners, LLC | 8950 | HQ | Brooklyn Center | MN | Midwest | Unknown | Medium | Olympus / Beckman AU | — | — | — | — | — | Analyzer Platform Purchasing Loss; 4 independent signals; trailing 90-day revenue $0.00 versus $819.44; trailing 180-day revenue $819.44 versus $3134.36; 21 days beyond expected account order date. | 578.73 | 1157.46 | 1736.19 | 230.7 | 461.39 | 692.09 | 71.57 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-dc22ebceaf1cbc63b420f962eaf787a5d4f17fe2387432957f7c920f3447b761 | Customer 8950 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-251f51991c750d3e2f9f450531beaedd0f0ac043e46731494f0b06f93f1cd62a | OPP-ea76a31643f1721044723e6c6769d80f74ddb323176346bda56343ae6380f7de | SER-0f5dea2380749cef12081f18e850951e9673f0aeed0c184cafb1af8d6dffa0db | Needs Validation | **** | **** | **** | Ashcroft Pathology Associates, Inc. | 9369 | Vendor | Eagen | MN | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 438 days beyond expected account order date. | 2468.03 | 4936.07 | 7404.1 | 770.56 | 1541.12 | 2311.69 | 71.19 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-251f51991c750d3e2f9f450531beaedd0f0ac043e46731494f0b06f93f1cd62a | Customer 9369 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5fdef91a9b8881160ca49ca4a9b438c6821e891e3d4a8672cbff433b684d582e | OPP-ba40782c95763917031c673c2c24951a90d6ebe1a16ef3e6a357ec14e0e7175c | SER-2926dbdb77d22230952997ace7194d9bcde8fcb24620cdd2e16750a85f045e31 | Needs Validation | **** | **** | **** | Ashcroft Pathology Associates, Inc. | 9369 | Vendor | Eagen | MN | Midwest | Unknown | Medium | — | — | — | — | — | — | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $3359.29 versus $6148.91; trailing 180-day revenue $9508.20 versus $14330.91; 5 days beyond expected account order date. | 1394.81 | 2789.62 | 4184.43 | 335.07 | 670.13 | 1005.2 | 61.74 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-5fdef91a9b8881160ca49ca4a9b438c6821e891e3d4a8672cbff433b684d582e | Customer 9369 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-72543ba995218cce51fe0a2bc072d4d994d7ed902c46319406a7647f0d18cce4 | OPP-ded686e2a48a280193ceff10b637d2986365efe583e817b78b9c02151704a486 | SER-b864128c2c426e974d98aab30df159e8056c617ff2dfe043468cbd5d89d56554 | Published | **** | **** | **** | Bridgeport Pathology Associates, Corp. | 9471 | Vendor | Vernon Hills | IL | Midwest | End-User Laboratory | High | — | MicroGenics | — | — | — | — | Product Family Purchasing Loss; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $915.90; 284 days beyond expected account order date. | 560.36 | 1120.73 | 1681.09 | 161.76 | 323.51 | 485.27 | 61.51 | Medium | False | False | — | CALL | Candidate CAND-72543ba995218cce51fe0a2bc072d4d994d7ed902c46319406a7647f0d18cce4 | Customer 9471 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8249e003c0738aae4b7d37a43b0c5a91c79a528a8a6f87516222096c755419b2 | OPP-11210c5c4d28439bc8f90e14ae40fb0bc78ecddcded070eabab2c0184c31f077 | SER-562fde078d4008363ef49401ebb9e200ce1abdc365c4b52058db2ad59e7dedca | Needs Validation | **** | **** | **** | Copperfield Medical Center, Inc. | 8959 | Vendor | Cleveland | OH | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $838.24 versus $790.54; trailing 180-day revenue $1628.78 versus $3480.30; -32 days beyond expected account order date. | 462.88 | 925.76 | 1388.64 | 174.92 | 349.84 | 524.76 | 57.79 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-8249e003c0738aae4b7d37a43b0c5a91c79a528a8a6f87516222096c755419b2 | Customer 8959 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2cb3ab3cd006af6e38490bb73a0d4a7c9ba85261410911ea696d5934725be3da | OPP-3061380af20c7f23daf81d2725ab42058220a19151f2428805839e34431fccb3 | SER-6f0661a21a2cee5934be4ed30f6e97316bbbed668e04fef72c4bb8017f74cf86 | Needs Validation | **** | **** | **** | Elmhurst Medical Associates, Inc. | 4488 | Vendor | Detroit | MI | Midwest | Research Institution Operating Instruments | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $63.45 versus $646.04; trailing 180-day revenue $709.49 versus $2116.87; -173 days beyond expected account order date. | 351.84 | 703.69 | 1055.53 | 101.14 | 202.28 | 303.42 | 53.39 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-2cb3ab3cd006af6e38490bb73a0d4a7c9ba85261410911ea696d5934725be3da | Customer 4488 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-98bb95b629b29ea8b8d5d97da811da571382af60f83320c0a8c6fd5fbb95a0ba | OPP-a7ebc9325a7b58c09336227ca29b637df80731c072b6ec6cdf86c808b754caed | SER-4feb5d6dcfb26f140c99c1a2895cb0a28588daa3443aa2c339c16aebef080d61 | Needs Validation | **** | **** | **** | Maple Physician Group, LLC | 8228 | HQ | Millersburg | OH | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $1896.00 versus $3792.00; trailing 180-day revenue $5688.00 versus $3696.00; -38 days beyond expected account order date. | 948 | 1896 | 2844 | 199.34 | 398.68 | 598.01 | 50.59 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-98bb95b629b29ea8b8d5d97da811da571382af60f83320c0a8c6fd5fbb95a0ba | Customer 8228 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d18e7a6f1284bce4ef074261dfc81586e65a41a3abac1851f0fc4257728e4b67 | OPP-531868d308e4d35e668015311421b6b7368d57511042c56ed4f0dd203865899a | SER-57dc7acfca95f9247b66476cdad520ecbbcfc4881e7f14fcdcab75fc4a30a988 | Published | **** | **** | **** | Maple Pathology Labs, LLC | 43803 | HQ | Irvine | CA | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $6586.38; trailing 180-day revenue $6586.38 versus $52563.01; 115 days beyond expected account order date. | 11494.16 | 22988.32 | 34482.47 | 3284.05 | 6568.09 | 9852.14 | 94.51 | High | False | True | — | CALL | Candidate CAND-d18e7a6f1284bce4ef074261dfc81586e65a41a3abac1851f0fc4257728e4b67 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4feefa73d6e35106488c98516e06b68aa887c69f0ba338055c87c91aa36e839f | OPP-ff5f08acf06cd52d664a1eae724e29c9f46ea62cfa0237efc8defb9d2f4c4404 | SER-fb78acf6069dc14e2af951d7a7bcb5f67f8077e2de1b2f7938ab6c643f7adddf | Published | **** | **** | **** | Crestview Medical Associates, LLC | 8532 | HQ | Sherman Oaks | CA | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 8 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4771.09; 235 days beyond expected account order date. | 4264.62 | 8529.24 | 12793.86 | 2159.63 | 4319.26 | 6478.89 | 92.53 | High | False | True | — | CALL | Candidate CAND-4feefa73d6e35106488c98516e06b68aa887c69f0ba338055c87c91aa36e839f | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e93cbbfc1d217adaa104b454407b50b763551867fb45096a07ddefa41e8a50e5 | OPP-d75ebe2c7f62f54b4eab3bc1cec7a92f4c39953135c2a3b29586990c05cc5eb8 | SER-aabea4e0be2e6424fb752eba0553124525a8bc5ffe8dfb576c91b08be4efb11d | Needs Validation | **** | **** | **** | Wrenfield Diagnostic Group, Corp. | 9912 | HQ | Lakeway | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 7 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4343.14; 278 days beyond expected account order date. | 5370.27 | 10740.53 | 16110.8 | 2021.39 | 4042.77 | 6064.16 | 87.48 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-e93cbbfc1d217adaa104b454407b50b763551867fb45096a07ddefa41e8a50e5 | Customer 9912 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d84fd79a3144001d9dbf1db8ca9270fdf12be619d8f0d7aac84dcb494c30af79 | OPP-aaddbe4414ac1dabd24ef114e567e84de427e89d7ae3e086c5f53a687f7f0ccc | SER-4facf7a8767b2f7ad8651e46cd8af9731394ed59577494f44339c753ff2ede76 | Published | **** | **** | **** | Cascade Diagnostic Labs, Inc. | 7758 | Vendor | Bridgeton | MO | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 5 independent signals; trailing 90-day revenue $588.70 versus $1858.20; trailing 180-day revenue $2446.90 versus $4223.68; 75 days beyond expected account order date. | 3408 | 6816 | 10224 | 947.18 | 1894.36 | 2841.54 | 82.61 | High | False | True | — | CALL | Candidate CAND-d84fd79a3144001d9dbf1db8ca9270fdf12be619d8f0d7aac84dcb494c30af79 | Customer 7758 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58ea338d72d11f4228eef1939f5d75af28ffafaf83d48c6b6ea20620773e3a00 | OPP-e8f9bd4862e93a07c52d5544449d81c27847c6eb1ad67d7145458dcd62f58c6b | SER-941d15c9a8cb6315c27c3bceb4bb853517d9af4aeebf74cfba264da2155c95bd | Needs Validation | **** | **** | **** | Maple Medical Partners, LLC | 9652 | HQ | San Antonio | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 8 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4452.06; 173 days beyond expected account order date. | 1113.02 | 2226.03 | 3339.05 | 411.74 | 823.47 | 1235.21 | 76.98 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-58ea338d72d11f4228eef1939f5d75af28ffafaf83d48c6b6ea20620773e3a00 | Customer 9652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-77908a4ebf80eb9b37d8f715fd9ac7f0255ca346c6637e0454c57ea5407697a3 | OPP-e1ff62615b9237873209a3f4d26e9d83e422f66ff8def3b3a6bd5c42288d7f92 | SER-dc1ba64a792b8e43c1b354cbcd8167eef158db0852a7345916c78cd652077ac1 | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, Inc. | 9452 | Vendor | Fremont | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $0.00 versus $2134.44; trailing 180-day revenue $2134.44 versus $0.00; 86 days beyond expected account order date. | 1067.22 | 2134.44 | 3201.66 | 338.68 | 677.35 | 1016.03 | 76.69 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-77908a4ebf80eb9b37d8f715fd9ac7f0255ca346c6637e0454c57ea5407697a3 | Customer 9452 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5705aabd14f45287b301619b55e092d55d0f428fad81301a64c7d81442afdb03 | OPP-f208049b7b4eafd44f063b2a8ffce8e5c5d7d8a9f2440209767ccbb36a107da0 | SER-e40a7a89f9dc6bc07ee4e8035ad58e9dd1906c585f81bdaae87baebbf69b737a | Needs Validation | **** | **** | **** | Brightwater Health Collective, PLLC | 9236 | Vendor | Escondido | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $3759.95; 153 days beyond expected account order date. | 939.99 | 1879.98 | 2819.96 | 264.63 | 529.27 | 793.9 | 76.53 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-5705aabd14f45287b301619b55e092d55d0f428fad81301a64c7d81442afdb03 | Customer 9236 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1e6025afadbaad47ca39c9aa54a4e17229acbd84b686271ade12ef54d7d606b7 | OPP-0b1826f854abcf2db4e9218f1f08d8a99c109641e2155f3fc72cb8cd81d37e98 | SER-5c5dadb91a54a43d10d603c6ba05337e36ecf54db75042f2ccc233743c60186d | Published | **** | **** | **** | Cedar Care Partners, Corp. | 8740 | HQ | McAllen | TX | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $2275.00 versus $650.00; trailing 180-day revenue $2925.00 versus $3250.00; -8 days beyond expected account order date. | 3253.12 | 6506.25 | 9759.37 | 2584.03 | 5168.05 | 7752.08 | 75.93 | Medium | False | True | — | CALL | Candidate CAND-1e6025afadbaad47ca39c9aa54a4e17229acbd84b686271ade12ef54d7d606b7 | Customer 8740 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2352ab42d340af5d5f7d70005b6bcc12a90bad14176257b0f5e35642b380ebc9 | OPP-82391ddcd7ec31bafad958c409ad611946a1ef936bd60651d5ea9f7e44c94138 | SER-9dc5f13cfd82ec31b777eba70d7cab1fede59f57a4c5597e6a2960b4cb677c56 | Needs Validation | **** | **** | **** | Lakeside Pathology Associates, Inc. | 42928 | HQ | Newport Beach | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 364 days beyond expected account order date. | 3024.36 | 6048.72 | 9073.08 | 1963.74 | 3927.48 | 5891.22 | 74.27 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-2352ab42d340af5d5f7d70005b6bcc12a90bad14176257b0f5e35642b380ebc9 | Customer 42928 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f4e2f8b39570890921206bd44fcccbddbd32d109e03653b1d32cead7cbee0c96 | OPP-a0955b595ac0dd024db582afae855eecc52a04ed790da6ae516361a5f0212c88 | SER-0c8b2d326a7b8211019247821e2276fb83a5c4ff5020549f20a03a1fccc52ec7 | Suppressed by Open Order | **** | **** | **** | Lakeside Pathology Associates, Inc. | 42928 | HQ | Pleasanton | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $10268.28 versus $18165.78; trailing 180-day revenue $28434.06 versus $21023.30; 11 days beyond expected account order date. | 3948.75 | 7897.5 | 11846.25 | 2160.06 | 4320.12 | 6480.19 | 73.22 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-f4e2f8b39570890921206bd44fcccbddbd32d109e03653b1d32cead7cbee0c96 | Customer 42928 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-22702106734b0087db39d76b324105a0a7dbb8086a5c6e6615f46ddf63b28597 | OPP-47d038964051c108fab0736b34825244a741c3fa0a3bc7c20aa66281e664b6b1 | SER-80ddfced1268966997b4ae8e661def1a4b472c969952f0b9dbe64739e1b6171b | Published | **** | **** | **** | Foothill Lab Services, LLC | 7734 | Vendor | San Bernardino | CA | Southwest | Research Institution Operating Instruments | High | Medica EasyRA | — | — | — | — | — | Analyzer Platform Purchasing Loss; 3 independent signals; trailing 90-day revenue $0.00 versus $306.76; trailing 180-day revenue $306.76 versus $2355.28; 61 days beyond expected account order date. | 512.13 | 1024.26 | 1536.39 | 145.19 | 290.39 | 435.58 | 72.01 | Medium | False | False | — | CALL | Candidate CAND-22702106734b0087db39d76b324105a0a7dbb8086a5c6e6615f46ddf63b28597 | Customer 7734 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-87cb49bb51e73b334a779f4eac4f65f9498b14fe238dc1719527f084c38bdce2 | OPP-2edd90d7bc1273edfe5c9f6c873389e3a4295765ead2fc8dc6ffd620d4d9ca47 | SER-2bb0bce5658ac7aea4ad287608af060dd6ee592fbb62b1492eb03f103e81e20d | Needs Validation | **** | **** | **** | Crestview Clinical Labs, PLLC | 10096 | Vendor | Penitas | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 4 independent signals; trailing 90-day revenue $435.87 versus $1307.61; trailing 180-day revenue $1743.48 versus $4772.10; 58 days beyond expected account order date. | 757.16 | 1514.31 | 2271.47 | 214.08 | 428.17 | 642.25 | 70.56 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-87cb49bb51e73b334a779f4eac4f65f9498b14fe238dc1719527f084c38bdce2 | Customer 10096 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-03cfceac620d00a5e48ca553c1cd29ab3d2a47200c36060aa6c189b745da97cb | OPP-7cc4eaf8b7e3f53b554576015b3678366af95d8d79146510aea684a5f0813061 | SER-0b2b87475dc0693edfb1bd41461a03722d0dd798118a319028605943e5486d79 | Published | **** | **** | **** | Copperfield Reference Labs, Corp. | 16404 | HQ | Laredo | TX | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 412 days beyond expected account order date. | 2739.98 | 5479.95 | 8219.93 | 1589.43 | 3178.87 | 4768.3 | 69.85 | Medium | False | False | — | Candidate CAND-03cfceac620d00a5e48ca553c1cd29ab3d2a47200c36060aa6c189b745da97cb | Customer 16404 | |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d166842e53af5630f1c8ee800fc00b3d2424cf2bda9cc0e3b8bac79a22321974 | OPP-86d90443a770bdaadbe73635a6f7dbbeeb81e2057be496b8c3f3dff4d425a9b3 | SER-fce3fea0dc3cd69fb062080b838e4dadf6e402e648679e57152965d127e9659c | Published | **** | **** | **** | Northgate Medical Associates, PLLC | 7098 | HQ | Redding | CA | Southwest | Hospital / Health System | High | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $843.28 versus $0.00; trailing 180-day revenue $843.28 versus $3689.46; 56 days beyond expected account order date. | 714.47 | 1428.94 | 2143.41 | 229.08 | 458.16 | 687.23 | 68.96 | Medium | False | False | — | CALL | Candidate CAND-d166842e53af5630f1c8ee800fc00b3d2424cf2bda9cc0e3b8bac79a22321974 | Customer 7098 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d5c80500e159f2bc3274644bc078cb685a88684f9e60653b528f5fc629cdd253 | OPP-f58bf18197927b204bba30baab3861d5edd90326dd1f3a063f310b4aec96c6bd | SER-74bbdae6f546b5a7990c8dc75d16635badbdf4bd2f0d355a19a8406abc4ab4be | Published | **** | **** | **** | Fairmont Health System, PLLC | 8961 | HQ | Los Angeles | CA | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 541 days beyond expected account order date. | 1301.52 | 2603.03 | 3904.55 | 963.21 | 1926.41 | 2889.62 | 68.16 | Medium | False | True | — | CALL | Candidate CAND-d5c80500e159f2bc3274644bc078cb685a88684f9e60653b528f5fc629cdd253 | Customer 8961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-be5d5fbacf6c3be4da35759370dd5158cf00e8d7da53b47088a6623724f380dd | OPP-f04e14f57eaaf545fd2db5b48ef79c632c3ef113d6a6b08d182c8c637f614a1c | SER-232b1e9b210236038c2407aa27fb285725461df52ed4e7c26ae5662cbdbd3718 | Needs Validation | **** | **** | **** | Wrenfield Diagnostic Group, Corp. | 9912 | Vendor | Austin | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $768.00 versus $4273.05; trailing 180-day revenue $5041.05 versus $963.00; 28 days beyond expected account order date. | 1752.53 | 3505.05 | 5257.58 | 350.84 | 701.69 | 1052.53 | 68.14 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-be5d5fbacf6c3be4da35759370dd5158cf00e8d7da53b47088a6623724f380dd | Customer 9912 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-081be5b39f9d623387ed168c6f4621403d0f69b5be0fbcc37bc31b00f7da9d22 | OPP-bf3adb8af888c38306a81dfde75e3a7bfc3d60d3e517f4a7584701890a7ba14b | SER-6489fe2564ff0a329ee0eb68c34be135aa32fc3101f8ffff41a86a77f4d46d02 | Published | **** | **** | **** | Sequoia Analytical Labs, PLLC | 13873 | HQ | Halton | TX | Southwest | Reseller | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 4 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $3000.00; 179 days beyond expected account order date. | 750 | 1500 | 2250 | 284.58 | 569.16 | 853.74 | 68.12 | Medium | False | False | — | CALL | Candidate CAND-081be5b39f9d623387ed168c6f4621403d0f69b5be0fbcc37bc31b00f7da9d22 | Customer 13873 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b02606235c45f564029c592dd6c5b37be9f1ca3559eaa07caceb964b463d11cb | OPP-c6f80dcebb2e3c0df13b383094ba39cf78c653df3adb5cbcea0c0139a770e486 | SER-949678cf0d85bc665306bd389565fbc1c8f6b74bbb5d0cdfa2dca42c0008f81e | Published | **** | **** | **** | Fairmont Medical Associates, PLLC | 8789 | HQ | Brighton | CO | Southwest | Reseller | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 397 days beyond expected account order date. | 1463.79 | 2927.57 | 4391.36 | 742.76 | 1485.52 | 2228.28 | 68.11 | Medium | False | True | — | CALL | Candidate CAND-b02606235c45f564029c592dd6c5b37be9f1ca3559eaa07caceb964b463d11cb | Customer 8789 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cf1c4b80902159f14ce2cb77a2b40e80028b2f01ae33e455c39ffb36b46e0bbe | OPP-ad9c21e24aa2cb25f1765cadde91796907ee642b6a66cc4668cf0307e87bcd9d | SER-27937a4bd45429cabf900e923b8becaf2b39585495d887a75d025063612dd929 | Needs Validation | **** | **** | **** | Ashcroft Care Partners, Inc. | 9422 | HQ | Irvine | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 428 days beyond expected account order date. | 1691.46 | 3382.92 | 5074.38 | 469.6 | 939.2 | 1408.8 | 66.36 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-cf1c4b80902159f14ce2cb77a2b40e80028b2f01ae33e455c39ffb36b46e0bbe | Customer 9422 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7a41fa6fede67ae37ac2afeba399a05cec87e980635b14966472041d8242d456 | OPP-d5d4aae3fa2b520916458f74edc5254ba8ba7eb620db6f1deba2b82537b79f35 | SER-e3f61c42b570f6d21fa53f90109e728581d9ad68930f66f40010ba3c1c59664f | Needs Validation | **** | **** | **** | Bellwood Laboratory Partners, Corp. | 10006 | HQ | Glendale | CA | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $421.64 versus $409.94; trailing 180-day revenue $831.58 versus $1229.82; -50 days beyond expected account order date. | 1019.81 | 2039.63 | 3059.44 | 425.3 | 850.59 | 1275.89 | 65.78 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-7a41fa6fede67ae37ac2afeba399a05cec87e980635b14966472041d8242d456 | Customer 10006 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-446dc0f0a8ab865fabb229529ec192618b4748bf67071edcd1b8b766d36433f9 | OPP-ef0d119f77d907d07c0382f7fb18beffbacda01e9d4720ef01e4ee06898c1992 | SER-ffb067669683170d5c58e7f02322cbeb3ba986d7d150679d2ac93f6bdde8ff20 | Needs Validation | **** | **** | **** | Harbor Analytical Labs, LLC | 9023 | HQ | Sugarland | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 5 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $3329.59; 193 days beyond expected account order date. | 832.4 | 1664.8 | 2497.19 | — | — | — | 64.8 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-446dc0f0a8ab865fabb229529ec192618b4748bf67071edcd1b8b766d36433f9 | Customer 9023 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fc3c3e894161a9c2766775a34023986a5653d17a7047e216d1fd7f09883f3ce4 | OPP-7552ec82393682a836fa00e7d15f0fa8b2c18efc67492741e3eb2ef9b7cb804f | SER-7f32a0abb1c349e3ca3ef368b962548084a3df748bb9f8778450c959bd25e54e | Needs Validation | **** | **** | **** | Silverline Diagnostics, Corp. | 7257 | HQ | Brea | CA | Southwest | Unknown | Medium | Parts Group | — | — | — | — | — | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1925.00; 168 days beyond expected account order date. | 601.56 | 1203.13 | 1804.69 | 148.44 | 296.87 | 445.31 | 64.46 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-fc3c3e894161a9c2766775a34023986a5653d17a7047e216d1fd7f09883f3ce4 | Customer 7257 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-27741e8dd856ca30ab8c391d15c194f02f94293e5a123f971c5a51cb60dac589 | OPP-ba177d1d92a26657f850aabdba452604dd256c94b22893c403836c2197ae7086 | SER-3aada101f3416f601b0de9051ce9dc17c3ec6b2c3785a912b7c409458e815cfe | Published | **** | **** | **** | Copperfield Diagnostic Group, Inc. | 7468 | Vendor | San Diego | CA | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 447 days beyond expected account order date. | 971.51 | 1943.02 | 2914.52 | 240.17 | 480.35 | 720.52 | 63.98 | Medium | False | False | — | CALL | Candidate CAND-27741e8dd856ca30ab8c391d15c194f02f94293e5a123f971c5a51cb60dac589 | Customer 7468 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ba763e9c3c07c5f726e0e8c2eb4df9a58994c7f4b303a66eb94a57684ed872c1 | OPP-6cc4ab87769cdc363ab5c802f51581f0f823860c939b49bcbd43ecdd9cd217b4 | SER-b90f441805d0de4ec1071a12ced627194d43624344fa0c3a215d472171ae58a6 | Published | **** | **** | **** | Riverside Health Alliance, PLLC | 10223 | Vendor | Tulsa | OK | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 374 days beyond expected account order date. | 1179.24 | 2358.49 | 3537.73 | 289.63 | 579.27 | 868.9 | 63.95 | Medium | False | True | — | CALL | Candidate CAND-ba763e9c3c07c5f726e0e8c2eb4df9a58994c7f4b303a66eb94a57684ed872c1 | Customer 10223 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3c560bfaa2a2d109c8e58e33415d36a09d2d8102f8def8e475d7cb1763854d6c | OPP-71f1384dab16c69eeea0af790f803277ba55dbd16ac9af25e64c83f03ffa066a | SER-dfbaaac0c7e991db0498a8aad21c68b0d93e918bf42013400425cc80838e4b95 | Published | **** | **** | **** | Copperfield Diagnostic Group, Inc. | 7468 | Vendor | San Diego | CA | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Materially Delayed Purchasing; 2 independent signals; trailing 90-day revenue $0.00 versus $1481.22; trailing 180-day revenue $1481.22 versus $2136.10; 92 days beyond expected account order date. | 740.61 | 1481.22 | 2221.83 | 218.83 | 437.66 | 656.49 | 63.13 | Medium | False | False | — | CALL | Candidate CAND-3c560bfaa2a2d109c8e58e33415d36a09d2d8102f8def8e475d7cb1763854d6c | Customer 7468 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4af4b56e9a32e5505ac2bb42202081d787d7ae86a6067dffc439e63430f0207b | OPP-46989f59dec46d5c4fdace870195c290c91c0d50e365da2a0893594537038319 | SER-341c47809d73bb819b682153302fe6719a0ff575e4f18e63ef1039ccd9dafc90 | Published | **** | **** | **** | Northgate Health Collective, PLLC | 5931 | HQ | Hesperia | CA | Southwest | End-User Laboratory | High | — | Beckman Access | — | — | — | — | Product Family Purchasing Loss; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $550.00; 286 days beyond expected account order date. | 662.85 | 1325.7 | 1988.55 | 213.69 | 427.37 | 641.06 | 61.89 | Medium | False | True | — | CALL | Candidate CAND-4af4b56e9a32e5505ac2bb42202081d787d7ae86a6067dffc439e63430f0207b | Customer 5931 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-614a05a9ec43ceb737660448acd1aa02d1efc2d7147b2b8477f2d33afb7ed5f6 | OPP-7cc0a3e2428e87dbd62488f94a5278e85156997cab70b17cd18ead91653514d6 | SER-efff5c574dbeaf78de8e7fe05be8c6c0ccb9f8f270f5edc86e6009529b1f2cf0 | Published | **** | **** | **** | Northgate Clinical Labs, PLLC | 33486 | Vendor | Tulsa | OK | Southwest | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1371.31 versus $3628.95; trailing 180-day revenue $5000.26 versus $4442.91; 10 days beyond expected account order date. | 1128.82 | 2257.64 | 3386.46 | 257.3 | 514.61 | 771.91 | 61.69 | Medium | False | False | — | CALL | Candidate CAND-614a05a9ec43ceb737660448acd1aa02d1efc2d7147b2b8477f2d33afb7ed5f6 | Customer 33486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-18c5881d260e0d021d4fe365b8448c5136378ceda5e762136344d456d4b7c782 | OPP-bb27c3fb428831df5f82384da811596b2d96d63234a6fa6ee2a42088beee9343 | SER-4a73be7984dee68644aefa937585b1da5a7e28ff043e9d5212b7ab4edfc11f52 | Published | **** | **** | **** | Riverside Health Alliance, PLLC | 10223 | HQ | Tulsa | OK | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 371 days beyond expected account order date. | 2084.8 | 4169.6 | 6254.39 | — | — | — | 61.58 | Medium | False | True | — | CALL | Candidate CAND-18c5881d260e0d021d4fe365b8448c5136378ceda5e762136344d456d4b7c782 | Customer 10223 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7f4c71a7ca6ef6c695077d5336efd2d9cf527134c19bdb36b786e262fc563e71 | OPP-bee8d875326c4b02290c151b2bd7fda5c64c3d626b420dfef464c18455e7a3e3 | SER-580d1cb2c5484f0bea729d215f2db8277135f2afe5a482c7a793b1f507e00a80 | Needs Validation | **** | **** | **** | Maple Medical Partners, LLC | 9652 | Vendor | San Antonio | TX | Southwest | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $775.05 versus $1321.44; trailing 180-day revenue $2096.49 versus $3984.99; 9 days beyond expected account order date. | 472.13 | 944.25 | 1416.38 | 92.71 | 185.42 | 278.12 | 58.53 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-7f4c71a7ca6ef6c695077d5336efd2d9cf527134c19bdb36b786e262fc563e71 | Customer 9652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58babf6d55a7496d8d89450be9ed558587ccf781d68e66066dba5839c728f9c6 | OPP-f896364439ead96dd23a6935fd4afdcdb0a5857cd1c2ec1b05d52bec480337fd | SER-89feaa0af8bfb427308a0af3a32f1e96bfb6f050a0cd80928ca6496335277895 | Needs Validation | **** | **** | **** | Cedar Medical Group, Corp. | 157 | HQ | McAllen | TX | Southwest | Unknown | Medium | Parts Group | — | — | — | — | — | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $4945.00 versus $0.00; trailing 180-day revenue $4945.00 versus $6410.00; -37 days beyond expected account order date. | 366.25 | 732.5 | 1098.75 | 208.97 | 417.94 | 626.91 | 57.77 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-58babf6d55a7496d8d89450be9ed558587ccf781d68e66066dba5839c728f9c6 | Customer 157 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aa7860e2e294c90acc58d7f4ec34204bae8e2dc4766826203f47009dfc5112c9 | OPP-16b483c37d30cd962cda436e95b2bab96e54621c3186147be0a4a875e734a915 | SER-c8dc4bde98403ac2aceebc9f15d2884b78a1e5f3ba6b8cc02789309d4d1119d3 | Needs Validation | **** | **** | **** | Bellwood Care Partners, Inc. | 39506 | HQ | Van Nuys | CA | Southwest | Research Institution Operating Instruments | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $790.00; trailing 180-day revenue $790.00 versus $2212.22; 105 days beyond expected account order date. | 395 | 790 | 1185 | 234.4 | 468.79 | 703.19 | 56.07 | Low | False | True | — | MANAGER_REVIEW | Candidate CAND-aa7860e2e294c90acc58d7f4ec34204bae8e2dc4766826203f47009dfc5112c9 | Customer 39506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-601e080aaa03443255a9b056640e10954b9207874ed3f52c85ab312fee8351fe | OPP-594e740861ad6284f35c8732e1b776bc4f10bf7c57b9b1f00d639442a1769995 | SER-d6ed8828c2d2aba741d277162f56aef77c77feeb5e7a0a6b870e1c7365d02b5d | Needs Validation | **** | **** | **** | Maple Health Collective, PLLC | 43173 | HQ | El Centro | CA | Southwest | Physician-Office Laboratory | High | — | — | — | — | — | — | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $1920.00 versus $2734.00; trailing 180-day revenue $4654.00 versus $2432.00; 16 days beyond expected account order date. | 407 | 814 | 1221 | 276.07 | 552.14 | 828.21 | 50.05 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-601e080aaa03443255a9b056640e10954b9207874ed3f52c85ab312fee8351fe | Customer 43173 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-66eb5e43946d5e5adf266503e659b25495e7a730bb9846ff4ff3370d69e96e2c | OPP-3f36c98563edcf04f7a0d6cdc4330ef82388067fb27cafaacfe6a3bf85b88547 | SER-09249c62747b8479ddd568c51e19b5ad0ddbb0cfbe3efa81995116ad8722f14c | Published | **** | **** | **** | Meridian Medical Center, LLC | 9097 | HQ | Miami | FL | Southeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $585.00 versus $3305.00; trailing 180-day revenue $3890.00 versus $5132.56; 7 days beyond expected account order date. | 3345.23 | 6690.46 | 10035.69 | 1929.83 | 3859.65 | 5789.48 | 86.49 | High | False | True | — | CALL | Candidate CAND-66eb5e43946d5e5adf266503e659b25495e7a730bb9846ff4ff3370d69e96e2c | Customer 9097 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-065ffc1c7cd358550724c262c5f64a00d626057d2f60f25bd8601ba75f7f9e82 | OPP-7b76e78886927f2309f8e6a2eff7a61308e69121871259a14cf2145f53eca62b | SER-5a0fe6dfa8f192620812e4a2b748d9ece39cce0aa081fd8c5f8bcf298cc9e4fc | Needs Validation | **** | **** | **** | Harbor Clinical Partners, LLC | 41977 | HQ | Ocala | FL | Southeast | Unknown | Medium | Bio-Rad | — | — | — | — | — | Analyzer Platform Purchasing Loss; 7 independent signals; trailing 90-day revenue $0.00 versus $1669.50; trailing 180-day revenue $1669.50 versus $12363.00; 66 days beyond expected account order date. | 2673.37 | 5346.75 | 8020.12 | 1374.22 | 2748.45 | 4122.67 | 84.14 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-065ffc1c7cd358550724c262c5f64a00d626057d2f60f25bd8601ba75f7f9e82 | Customer 41977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6fa0e69d8f84540b93a97c7e18534de132ede5e6f5cd38caabd9bff36e91e37d | OPP-2881a54bb0fac6b07a4b4553827ab5789dd1a96a09e3e3688756a5763dc3ea09 | SER-de0f4e96912a14cfb7273c34cd49968e99e8d5e12c00137bb89af6e1d5e648c5 | Suppressed by Open Order | **** | **** | **** | Summit Clinical Labs, Corp. | 9122 | HQ | Miami | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $5081.23; trailing 180-day revenue $5081.23 versus $3095.65; 98 days beyond expected account order date. | 2540.62 | 5081.23 | 7621.85 | 749.48 | 1498.97 | 2248.45 | 82.76 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-6fa0e69d8f84540b93a97c7e18534de132ede5e6f5cd38caabd9bff36e91e37d | Customer 9122 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-10b13cf548d302262c2954375fcb4b5132517bb1e6e0de508d0152e01288e31f | OPP-87c8154c6286c9ebe072be1f1fcd9f851033f360024955d231f33ae1e3dba7f8 | SER-f8d5f2a2a0db55aea9d178bf758b5779423a7efe37861bef0160ceda58756247 | Needs Validation | **** | **** | **** | Whitmore Diagnostic Labs, LLC | 10321 | HQ | Las Vegas | NV | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $620.64 versus $8715.94; trailing 180-day revenue $9336.58 versus $5340.08; -30 days beyond expected account order date. | 4047.65 | 8095.3 | 12142.95 | 1349.23 | 2698.47 | 4047.7 | 82.49 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-10b13cf548d302262c2954375fcb4b5132517bb1e6e0de508d0152e01288e31f | Customer 10321 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0d4c4cbc6870e1ba161ab4b86d1510bfd0dd601794d50ec586d6d608f1b09529 | OPP-77766cb3c38198e48d3700236364c3938afa21b840a80e5049cd91d3de8f2ba6 | SER-3768c9cbd11fb4631a54602caeed36774201c4d18ba9db049a577fd5e656418f | Published | **** | **** | **** | Bridgeport Medical Center, Corp. | 44236 | HQ | Fayette | MS | Southeast | Hospital / Health System | High | Abbott i-STAT | — | — | — | — | — | Analyzer Platform Purchasing Loss; 6 independent signals; trailing 90-day revenue $0.00 versus $54.21; trailing 180-day revenue $54.21 versus $9999.04; 81 days beyond expected account order date. | 2486.21 | 4972.42 | 7458.62 | 780.71 | 1561.42 | 2342.14 | 81.87 | High | False | True | — | CALL | Candidate CAND-0d4c4cbc6870e1ba161ab4b86d1510bfd0dd601794d50ec586d6d608f1b09529 | Customer 44236 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9b6a5f30e81ca9fa8589c3bfcce7ca833b64c525b9395149a72cf34ed3b4ccd3 | OPP-cb0483b5c8e2b27d98b8ca36925b26c174f494bdfbd5ff7dcfaa65c242af5ce3 | SER-1351d31304a49bc57cee8ccb3bf16a0e4bedba535ff7669f45cb157f1c9902dd | Needs Validation | **** | **** | **** | Harbor Clinical Partners, LLC | 41977 | HQ | Chiefland | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $3697.38; trailing 180-day revenue $3697.38 versus $2032.11; 103 days beyond expected account order date. | 1848.69 | 3697.38 | 5546.07 | 1015.97 | 2031.94 | 3047.91 | 79.78 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-9b6a5f30e81ca9fa8589c3bfcce7ca833b64c525b9395149a72cf34ed3b4ccd3 | Customer 41977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | OPP-00fd7f07efeb44ad644865feabb88a6d4a86a5f263841b752f106ec908b3c327 | SER-5bac9f71d31fd3bd2c2eda5505ba8c67a094ed11888d590c07b3f174ca68ae6c | Needs Validation | **** | **** | **** | Ashcroft Laboratory Partners, Inc. | 6935 | HQ | Nogales | AZ | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $4586.25; trailing 180-day revenue $4586.25 versus $2476.92; 82 days beyond expected account order date. | 2293.13 | 4586.25 | 6879.38 | 655.2 | 1310.4 | 1965.59 | 77.01 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | Customer 6935 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-612521b4efa5ba67ee0ca409ddbc1572233ff94fa4a4539ece35bea60fe1d33b | OPP-69702c0d6d3c81e727945fb17797bc2516f819de12194a13ba51588d31c3f50e | SER-ded90c6e62bc586c0ea628db711ba1617f0fb9ec97a5e40eaa3743aea8bdf30c | Published | **** | **** | **** | Bridgeport Care Partners, Corp. | 41006 | HQ | Alexandria | LA | Southeast | Research Institution Operating Instruments | High | — | Bio-Rad | — | — | — | — | Product Family Purchasing Loss; 3 independent signals; trailing 90-day revenue $5121.25 versus $0.00; trailing 180-day revenue $5121.25 versus $13036.40; 11 days beyond expected account order date. | 1978.79 | 3957.58 | 5936.36 | 689.18 | 1378.37 | 2067.55 | 76.22 | High | False | True | — | CALL | Candidate CAND-612521b4efa5ba67ee0ca409ddbc1572233ff94fa4a4539ece35bea60fe1d33b | Customer 41006 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b1406af50f7fddec238bbe5367cdf24560947c3dbad0c8a122f5ab1e9cb9705c | OPP-6c9430ea68121d13192d0440e7b6fb999c99e915bb4b7ed3ac6059f2eb7628e4 | SER-068171fb07ebdf5154211e347ed9a6e2bd996b03d5ae0c31c0d463512095df5d | Published | **** | **** | **** | Ironwood Diagnostic Labs, Inc. | 10198 | Vendor | Boca Raton | FL | Southeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 5 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4402.70; 180 days beyond expected account order date. | 1100.68 | 2201.35 | 3302.03 | 418.22 | 836.45 | 1254.67 | 74.74 | Medium | False | False | — | CALL | Candidate CAND-b1406af50f7fddec238bbe5367cdf24560947c3dbad0c8a122f5ab1e9cb9705c | Customer 10198 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e36aeee51baa0898860970a1fc2a06b4ff920f4f9f8e19a7299d9eeb62ea9ab2 | OPP-b4c9546048f766f89f05e442a4553600e7614e2a22d56d7483e3f1905f2977c5 | SER-4867b49d1be340cdc90a676c0549117d29993fac662b4b862e39fbb70d34c9dd | Published | **** | **** | **** | Whitmore Laboratory Partners, PLLC | 41400 | HQ | Birmingham | AL | Southeast | Reseller | High | — | — | — | — | — | — | Revenue Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $2374.63; trailing 180-day revenue $2374.63 versus $9575.24; 82 days beyond expected account order date. | 1800.15 | 3600.31 | 5400.46 | — | — | — | 74.12 | High | False | False | — | CALL | Candidate CAND-e36aeee51baa0898860970a1fc2a06b4ff920f4f9f8e19a7299d9eeb62ea9ab2 | Customer 41400 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7a3391138c6f56eb90b50e3aa0010ac8f85256511f8e564fbd3a43cfac5257a5 | OPP-c5e47fb201019edad3142da92dabb462024543b730ee04cfd29a2c555f65ead8 | SER-9f2edc5f7bd97670e4772cf58285b09e4f60bf8b0b1f293f4b7d5660beaa9109 | Published | **** | **** | **** | Foothill Care Partners, Inc. | 9091 | Vendor | Biloxi | MS | Southeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $5133.41 versus $940.21; trailing 180-day revenue $6073.62 versus $11813.54; 9 days beyond expected account order date. | 1434.98 | 2869.96 | 4304.94 | 485.93 | 971.86 | 1457.79 | 70.75 | High | False | True | — | CALL | Candidate CAND-7a3391138c6f56eb90b50e3aa0010ac8f85256511f8e564fbd3a43cfac5257a5 | Customer 9091 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9f980691a528d70ea58fd234640baac8bd36a6d0623cf363a0b4307c4acfd048 | OPP-e58d561ac927eccb68c8d1931924606eae9690aa3ebccb24bf08164bdbce0a3a | SER-da5f2895db6c532118fd920cb1cdf90061ac2758f04a124231d16d776912cf0e | Needs Validation | **** | **** | **** | Cedar Diagnostics, Corp. | 9053 | HQ | Gainesville | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Complete Purchasing Cessation; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $2600.00; 225 days beyond expected account order date. | 650 | 1300 | 1950 | 109.3 | 218.6 | 327.9 | 70.41 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-9f980691a528d70ea58fd234640baac8bd36a6d0623cf363a0b4307c4acfd048 | Customer 9053 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b0c3c43f70122624c31cc183c312fb05c0feacb0f311c976e8ef86558312f78f | OPP-a26974fc5d68a0988606450c99f47a035510b48955e0a670c10fae87a68badb7 | SER-e543b6d5fecc74bfe7fefa8477850d1498b13073abfea5ff79fde57170d03b56 | Published | **** | **** | **** | Crestview Clinical Labs, LLC | 52791 | HQ | Hollywood | FL | Southeast | Research Institution Operating Instruments | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $79.53 versus $3279.52; trailing 180-day revenue $3359.05 versus $409.94; 24 days beyond expected account order date. | 1600 | 3199.99 | 4799.99 | 504.82 | 1009.63 | 1514.45 | 69.05 | High | False | False | — | ENRICH_CONTACT | Candidate CAND-b0c3c43f70122624c31cc183c312fb05c0feacb0f311c976e8ef86558312f78f | Customer 52791 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-944a1d4b4254f399f7e05fb439e44c57c757067ae88a121828c9c270834f2e27 | OPP-b278114fd91d564d0a726b2dcbab796dec84dd8b6e40deda8175981945317aa1 | SER-3d735697b0aa2a50f76a58f0485d0b70fcb05e382e9d835af21ef08eda6eb691 | Needs Validation | **** | **** | **** | Cascade Medical Center, Inc. | 41477 | Vendor | Mesa | AZ | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1174.54 versus $0.00; trailing 180-day revenue $1174.54 versus $4846.75; -4 days beyond expected account order date. | 1091.36 | 2182.73 | 3274.09 | 286.36 | 572.72 | 859.07 | 68.62 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-944a1d4b4254f399f7e05fb439e44c57c757067ae88a121828c9c270834f2e27 | Customer 41477 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78b6d4268f28a1ac8dc09358801c3297bf0da4730b9fd52db51886c81843479c | OPP-f7c9a64024e61dcfdf67221e1735843a9dd78441638bcb10eec60fa7c84ad6ac | SER-22e7a611d17b2845004f031716129b90f62ccdfac1a040365f33e321575b84f9 | Needs Validation | **** | **** | **** | Ironwood Medical Center, Inc. | 9329 | Vendor | Chandler | AZ | Southeast | Unknown | Medium | MicroGenics | — | — | — | — | — | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1689.45; 248 days beyond expected account order date. | 639.76 | 1279.53 | 1919.29 | 170.15 | 340.31 | 510.46 | 67.02 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-78b6d4268f28a1ac8dc09358801c3297bf0da4730b9fd52db51886c81843479c | Customer 9329 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a9d50945098a411c38c75568cefaa98e91e1e255e02a8ab04202cb40d5f6efd2 | OPP-f5a32225f106041ea963002b28e5f95332810d601f749249013d6f9c2e8c6288 | SER-055086261610be93848d47d65d0a035c74a89116fbc92c5eba5bb2a94db78a9c | Published | **** | **** | **** | Riverside Health Collective, PLLC | 8651 | Vendor | Stuart | FL | Southeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 2 independent signals; trailing 90-day revenue $5026.48 versus $5863.93; trailing 180-day revenue $10890.41 versus $19475.41; -1 days beyond expected account order date. | 2146.25 | 4292.5 | 6438.75 | 588.39 | 1176.78 | 1765.17 | 65.79 | High | False | False | — | CALL | Candidate CAND-a9d50945098a411c38c75568cefaa98e91e1e255e02a8ab04202cb40d5f6efd2 | Customer 8651 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5f99aa6dd7843b9d55a38dddec87f52c40948d3f770540874d134ca5adce1684 | OPP-10fc50982d40ca16572875d6e6275d828ea65e392213cb2f196d8897197e66c2 | SER-1b97245ff6230039e265760760f441ea10c7b816f9d19f22b50cf18601fc5558 | Needs Validation | **** | **** | **** | Cascade Medical Center, Inc. | 41477 | HQ | Mesa | AZ | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $138.35; 271 days beyond expected account order date. | 1240.77 | 2481.54 | 3722.31 | — | — | — | 65.4 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-5f99aa6dd7843b9d55a38dddec87f52c40948d3f770540874d134ca5adce1684 | Customer 41477 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-993200c8f4a375c3d0d49f5508a73c6ef44a81867f876d1aec038210f74eee5e | OPP-f0189e82ee704b7f4e203c25fb119bf381f6c04474ede666db544e5ec33a4747 | SER-7639f30f5000ef5bb3fc38cfb01f51a52a7e2aecb4dec0b147b8f27a966e5b2d | Published | **** | **** | **** | Ashcroft Laboratory Partners, Corp. | 8384 | Vendor | Jacksonville | FL | Southeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 450 days beyond expected account order date. | 1404.96 | 2809.92 | 4214.87 | 460.62 | 921.25 | 1381.87 | 63.53 | Medium | False | False | — | CALL | Candidate CAND-993200c8f4a375c3d0d49f5508a73c6ef44a81867f876d1aec038210f74eee5e | Customer 8384 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4b42c74c13c49d85e53a2d4cd4f00900d91b7506a63f3d056cd12c74603d784c | OPP-edec11a1b0a84207ff281877c4a9ebd38183dfc8860a3c27fb0dac64fe077273 | SER-a2c6a9cc2406df9926cae28c1f555b49d7e6170988243db2253df7994ec492c1 | Needs Validation | **** | **** | **** | Ironwood Medical Center, Corp. | 9695 | HQ | Neptune Beach | FL | Southeast | Unknown | Medium | — | Beckman Access | — | — | — | — | Product Family Purchasing Loss; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $530.00; 325 days beyond expected account order date. | 743.82 | 1487.64 | 2231.46 | 363.18 | 726.36 | 1089.54 | 63.43 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-4b42c74c13c49d85e53a2d4cd4f00900d91b7506a63f3d056cd12c74603d784c | Customer 9695 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c0005030adc8329eb42108cc41a43ee93f410f66d1efaa55f3aa46c45fcc4428 | OPP-2934a96fe4a9321e5bd24a36cb5e89a72e3378cfe2b0b625ad269ab2157f26b6 | SER-663f7042f61c3b8ff18408fd052fe0eaba7f3b39e619a7be16aaa3c78f3a2f3c | Published | **** | **** | **** | Ashcroft Laboratory Partners, Corp. | 8384 | HQ | Jacksonville | FL | Southeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 466 days beyond expected account order date. | 2774.71 | 5549.42 | 8324.13 | — | — | — | 63.19 | Medium | False | True | — | CALL | Candidate CAND-c0005030adc8329eb42108cc41a43ee93f410f66d1efaa55f3aa46c45fcc4428 | Customer 8384 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5600720df21275563c2e46714e0f1083e696fd63b127b71e1f0ea8a3bd360453 | OPP-1ff1b603e8c440e3b484275fce240884d6df515b11ae83b0e950b64adb2b6cc9 | SER-8296f8652d6f6f8b1deb559d33baa1716f51cc95993f4a6cba73c8c747c90c14 | Published | **** | **** | **** | Wrenfield Medical Group, Corp. | 1435 | Vendor | Atlanta | GA | Southeast | Research Institution Operating Instruments | High | — | — | — | — | — | — | Reduced Order Frequency; 2 independent signals; trailing 90-day revenue $0.00 versus $1004.51; trailing 180-day revenue $1004.51 versus $793.84; 0 days beyond expected account order date. | 502.25 | 1004.51 | 1506.76 | 143.5 | 287 | 430.5 | 63.05 | Medium | False | False | — | CALL | Candidate CAND-5600720df21275563c2e46714e0f1083e696fd63b127b71e1f0ea8a3bd360453 | Customer 1435 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ed65670f60e4bc72945a4ecaf182bfa951ffab26ff9ce56ef08d9f17ff14f4d9 | OPP-9f97d19a9f37ff6f242044f17a60cbe4e971cf21ef553b13c5a7eaf62fa34748 | SER-1cd0c51a03bc53984651c265a907869aa48b52ab33b287eade6bd55dab13e0c5 | Needs Validation | **** | **** | **** | Harbor Analytical Labs, PLLC | 3669 | HQ | Miramar | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $1917.60 versus $4119.00; trailing 180-day revenue $6036.60 versus $3285.00; -8 days beyond expected account order date. | 1100.7 | 2201.4 | 3302.1 | 436 | 872 | 1308 | 61.55 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-ed65670f60e4bc72945a4ecaf182bfa951ffab26ff9ce56ef08d9f17ff14f4d9 | Customer 3669 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-db834e1034b7407206687ee64e55b7d206554d23b314e06e33e5309e8857301e | OPP-f844ec195e898e489eaa8e20d74e604fa59bf276a8dbc66532a08c7c0f8b9eb7 | SER-4488913a4c4d6054ffd87e56017d8418c8f68d52748333c834baa07a932de354 | Needs Validation | **** | **** | **** | Meridian Lab Services, Corp. | 9385 | HQ | Miami | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $2150.40; trailing 180-day revenue $2150.40 versus $1519.76; 20 days beyond expected account order date. | 1075.2 | 2150.4 | 3225.6 | 322.02 | 644.05 | 966.07 | 60.47 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-db834e1034b7407206687ee64e55b7d206554d23b314e06e33e5309e8857301e | Customer 9385 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8eaa9b711fbf3e92ada013c68eabf8a8b7b65828e34a3a13dec060c5b9027ccd | OPP-b013cd9741a699064f510dceb9dafa6359b09ac5f79269ff785fd72aea3619c0 | SER-a892d8224cd3a8e06b897975c860b712848f7164025875b6637b775b3a31b2c5 | Needs Validation | **** | **** | **** | Ironwood Medical Center, Inc. | 9329 | HQ | Mesa | AZ | Southeast | Unknown | Medium | — | Greiner Bio-One | — | — | — | — | Product Family Purchasing Loss; 3 independent signals; trailing 90-day revenue $2364.33 versus $1802.43; trailing 180-day revenue $4166.76 versus $7663.33; -6 days beyond expected account order date. | 874.14 | 1748.29 | 2622.43 | 227.65 | 455.3 | 682.95 | 60.41 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-8eaa9b711fbf3e92ada013c68eabf8a8b7b65828e34a3a13dec060c5b9027ccd | Customer 9329 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9e52da3c108d6b6d434bf5216de676880966c12b94b334fb31257a267f793bfc | OPP-e9fc416c60a0da7d61211040670dfe1a8a534fb17fdf3d83445ce1e34412b037 | SER-a2badd8e5ca36602954559c55053486cdc8244081c7ce9f2db652bad94516e9a | Suppressed by Open Order | **** | **** | **** | Harbor Health Collective, PLLC | 8934 | HQ | Clermont | FL | Southeast | End-User Laboratory | High | — | — | — | — | — | — | Account Risk; 1 independent signal; trailing 90-day revenue $8278.76 versus $12724.76; trailing 180-day revenue $21003.52 versus $23259.09; -1 days beyond expected account order date. | 2223 | 4446 | 6669 | 835.28 | 1670.56 | 2505.84 | 59.88 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-9e52da3c108d6b6d434bf5216de676880966c12b94b334fb31257a267f793bfc | Customer 8934 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f9b59d4821538633d8c1b4744ba879d9428917b06daf48dc8183260bb0b7780e | OPP-9dddb32fc36787a125630f4f52dd13ff5ae782807606d42c52e1315ad36748cf | SER-f89fb09a9544496c3eaf4318e23e0df01ca13c73d90f43d451e9dc5e801e4545 | Needs Validation | **** | **** | **** | Elmhurst Medical Associates, Corp. | 8880 | HQ | Nogales | AZ | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 419 days beyond expected account order date. | 1196.33 | 2392.66 | 3588.99 | 341.81 | 683.63 | 1025.44 | 59.13 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-f9b59d4821538633d8c1b4744ba879d9428917b06daf48dc8183260bb0b7780e | Customer 8880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-610bb4bcacbd83872f739f249cd8c7e434098921ad48a71f459741ac38775494 | OPP-c33b53f1f29aecf587cd9a2e0e58001cacee8297d631fdf9890f788c8bacf37d | SER-878445b26adba8fe6912c0be3846b6071846db5937eeb62adef257ac26d8f215 | Needs Validation | **** | **** | **** | Cedar Diagnostics, Corp. | 9053 | HQ | Gainesville | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $1300.00 versus $3900.00; trailing 180-day revenue $5200.00 versus $4550.00; -7 days beyond expected account order date. | 1300 | 2600 | 3900 | 181.77 | 363.54 | 545.31 | 58.61 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-610bb4bcacbd83872f739f249cd8c7e434098921ad48a71f459741ac38775494 | Customer 9053 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a851bc2d7bc2d104cd2109c86f064ab43299bb40675af0038efceb31b245bc8d | OPP-1576f4ed9434c2da5eec6e862128b82a95fc80cdf14952cfda79315cc7687dbc | SER-63550abf625af7c8f4484615ebc1c14b489b38289993ad0435f86091454f7617 | Needs Validation | **** | **** | **** | Northgate Medical Partners, Inc. | 9241 | HQ | Koutiala | GA | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $2459.64; trailing 180-day revenue $2459.64 versus $2459.64; 1 days beyond expected account order date. | 1229.82 | 2459.64 | 3689.46 | 397.62 | 795.25 | 1192.87 | 57 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-a851bc2d7bc2d104cd2109c86f064ab43299bb40675af0038efceb31b245bc8d | Customer 9241 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | OPP-cc5f7d563542da0d509157ae870789bcb9e5e026ffadc7ab0dd9e285848a9553 | SER-d1d41c1aa5f24257974431a9a474b2eb76a8ebf525c9c8f1834172b91419d745 | Needs Validation | **** | **** | **** | Silverline Diagnostic Group, Inc. | 9880 | HQ | Las Vegas | NV | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1038.22 versus $2321.84; trailing 180-day revenue $3360.06 versus $4993.53; 7 days beyond expected account order date. | 641.81 | 1283.62 | 1925.43 | — | — | — | 56.35 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | Customer 9880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bceef6fc998198e3752ed0e5ef54a52eb18b4dad6aa5e9f5881e0cd57aaeedce | OPP-18b15873f06ce2f3feb025367e842e304b307811d1330be96e9047e5ac6973a8 | SER-a004b1310ed41498ce2c61ed0e4b04230d26321433034c108f6cd5fa49923909 | Published | **** | **** | **** | Bridgeport Care Partners, Corp. | 41006 | HQ | Homer | LA | Southeast | Research Institution Operating Instruments | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $2078.27 versus $0.00; trailing 180-day revenue $2078.27 versus $2275.45; -124 days beyond expected account order date. | 616.76 | 1233.52 | 1850.27 | 305.97 | 611.94 | 917.9 | 55.88 | Medium | False | False | — | CALL | Candidate CAND-bceef6fc998198e3752ed0e5ef54a52eb18b4dad6aa5e9f5881e0cd57aaeedce | Customer 41006 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | OPP-e352db033ac82525589dca9a4534f296794f231b94219711e86da965b5ec6822 | SER-1c8630707d43926be2757a2b8c57ba7df96248fbf52c7bc463f55e5ee7670b81 | Needs Validation | **** | **** | **** | Silverline Diagnostic Group, Inc. | 9880 | Vendor | Las Vegas | NV | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $951.03 versus $1862.23; trailing 180-day revenue $2813.26 versus $2847.74; 23 days beyond expected account order date. | 775.5 | 1550.99 | 2326.49 | 155.79 | 311.59 | 467.38 | 55.43 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | Customer 9880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fe76b9f93ad4504b4ea87ee71d488e3b8c84ddf4ccbdd8d077898121130bb75b | OPP-7870b625dd94538c3b0793aaccdb2b699623ec845946ab0a36d2d1eae6e09151 | SER-dd4d7683fd4edcf762e9495fcc79e37965fd3e82d7e2db91f03870742e222992 | Published | **** | **** | **** | Bellwood Reference Labs, Corp. | 44704 | HQ | Buckeye | LA | Southeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $443.00 versus $402.98; trailing 180-day revenue $845.98 versus $3626.82; -56 days beyond expected account order date. | 695.21 | 1390.42 | 2085.63 | 256.78 | 513.56 | 770.34 | 52.33 | Medium | False | False | — | ENRICH_CONTACT | Candidate CAND-fe76b9f93ad4504b4ea87ee71d488e3b8c84ddf4ccbdd8d077898121130bb75b | Customer 44704 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-581ff99de969a0646093040b5c6680d6c5a7aefde2343de98fb0d7759c4b8de2 | OPP-0b8889dcda962328d3bb57d5a6795f4a18054b14d54d32eb3b9cbf96dcdb3f60 | SER-bf294c8f1b8fdbd2b96b5dd905c217bf11aa006ab58351267278de70e9ed2583 | Needs Validation | **** | **** | **** | Brightwater Clinical Labs, LLC | 8624 | HQ | Miami | FL | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $3480.00 versus $0.00; trailing 180-day revenue $3480.00 versus $0.00; -165 days beyond expected account order date. | 510 | 1020 | 1530 | 159.73 | 319.46 | 479.19 | 49.31 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-581ff99de969a0646093040b5c6680d6c5a7aefde2343de98fb0d7759c4b8de2 | Customer 8624 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a53bf0a3528f350a040b4a0806d951d1ba449d7d341046673cd12f3b3ce6536f | OPP-01acde0ac3ceb28aa82be004c1c1811c2ef7fdb8f51c7e3e6108b293a8ef48cf | SER-92c3eb961900f42eb4652cc5ad9ad68125838c85654b76bbac7fa581224ca065 | Needs Validation | **** | **** | **** | Whitmore Laboratory Partners, Inc. | 7879 | HQ | Massapequa | NY | Northeast | Unknown | Medium | Bio-Rad | — | — | — | — | — | Analyzer Platform Purchasing Loss; 7 independent signals; trailing 90-day revenue $5826.48 versus $13597.34; trailing 180-day revenue $19423.82 versus $5642.66; 55 days beyond expected account order date. | 9849.69 | 19699.38 | 29549.06 | 6826.99 | 13653.99 | 20480.98 | 94.17 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-a53bf0a3528f350a040b4a0806d951d1ba449d7d341046673cd12f3b3ce6536f | Customer 7879 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fd39fd637227988a474416789c88a2c31e970625aaa9100464c8f17856c82b4a | OPP-2cabf8cb6d41084d7cb47b8b077cc5643029027d3beab3f2b7b834168c0df4df | SER-53368dabd982aa1b9f16f2e7f35f6efab95463e502734ff10b4873b97aed6fa6 | Suppressed by Open Order | **** | **** | **** | Sequoia Health Alliance, LLC | 7690 | HQ | Haledon | NJ | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 4 independent signals; trailing 90-day revenue $11205.84 versus $45217.29; trailing 180-day revenue $56423.13 versus $17268.67; 21 days beyond expected account order date. | 17005.72 | 34011.45 | 51017.17 | 7373.31 | 14746.61 | 22119.92 | 93.49 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-fd39fd637227988a474416789c88a2c31e970625aaa9100464c8f17856c82b4a | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0ce2edb057d016ac05beda7a80186e9931177d2868629a2c0a73255fe99eab06 | OPP-5ed0d0c81e04d0e88bb62923b9099d7efbf8bedf7c869629b7039257a1fa6496 | SER-58273b8e11091d5799fa225d10a884cb99b99cbd787e1679eb88f1bdaab689a9 | Published | **** | **** | H | Cedar Lab Services, LLC | 6977 | HQ | Kenilworth | NJ | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | — | — | — | — | — | Analyzer Platform Purchasing Loss; 7 independent signals; trailing 90-day revenue $1145.37 versus $609.48; trailing 180-day revenue $1754.85 versus $23856.84; 13 days beyond expected account order date. | 14510.07 | 29020.13 | 43530.2 | 9421.03 | 18842.05 | 28263.08 | 92.7 | High | False | True | — | CALL | Candidate CAND-0ce2edb057d016ac05beda7a80186e9931177d2868629a2c0a73255fe99eab06 | Customer 6977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-51814804149304927da6cad598af1db70a01552667b3746aaaf86726379a08bb | OPP-a423420a165ff0c0abc869590ab7e246fbc5551fc36a983cc99b822b2a61007b | SER-598bbcae822dd4f273c8b8d5bdd363ec7a7eb43d3cdac9a5aa1666a7c0816418 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | Norwood | MA | Northeast | End-User Laboratory | High | — | Bio-Rad | — | — | — | — | Product Family Purchasing Loss; 5 independent signals; trailing 90-day revenue $3217.79 versus $10768.14; trailing 180-day revenue $13985.93 versus $24800.28; -5 days beyond expected account order date. | 3775.18 | 7550.35 | 11325.53 | 1356.45 | 2712.9 | 4069.35 | 87.59 | High | False | True | — | CALL | Candidate CAND-51814804149304927da6cad598af1db70a01552667b3746aaaf86726379a08bb | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d49ed70ad95cc7a4f27eb9496f89a12a61f53d2b10a1f1ba94fcc6989d596e0e | OPP-32cbd3a93210eaafb7f29f3cdbf9bac7ca46a46cf8369e548938fe62ab70796c | SER-e66e63ffa0b217563b2c65a5d8ad227d6e252c66c1bbd68ec477b480d2e3ab17 | Published | **** | **** | **** | Stonebridge Physician Group, LLC | 927 | HQ | Mansfield | MA | Northeast | Reseller | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 4 independent signals; trailing 90-day revenue $0.00 versus $6884.70; trailing 180-day revenue $6884.70 versus $6196.23; 64 days beyond expected account order date. | 3442.35 | 6884.7 | 10327.05 | 1235.53 | 2471.06 | 3706.6 | 87.59 | High | False | False | — | CALL | Candidate CAND-d49ed70ad95cc7a4f27eb9496f89a12a61f53d2b10a1f1ba94fcc6989d596e0e | Customer 927 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-62134774fd802ef7769eec272e1cea305568918c5d6bdafafb303f2dd3e3d2a9 | OPP-7227bb3428add66fc02531b3979154a10899137bedff82cdca42a0f815ef0e88 | SER-62be7e6751896bd3a04303aaf1443858b126a2aeac864e7208221bc76f982892 | Published | **** | **** | **** | Summit Health System, Inc. | 5175 | Vendor | Jamaica | NY | Northeast | Distributor | High | Fisher Chemical | — | — | — | — | — | Analyzer Platform Purchasing Loss; 4 independent signals; trailing 90-day revenue $1754.70 versus $2226.93; trailing 180-day revenue $3981.63 versus $15193.34; -9 days beyond expected account order date. | 2802.93 | 5605.86 | 8408.78 | 626.08 | 1252.16 | 1878.23 | 85.07 | High | False | True | — | CALL | Candidate CAND-62134774fd802ef7769eec272e1cea305568918c5d6bdafafb303f2dd3e3d2a9 | Customer 5175 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c4a42b6740cc1541f51908edf4b19e8e81ff8f16a5a0c5d6041c738da0684406 | OPP-b619f45d3ef53a1cd830aaf6a1cd0d5522052022787ddc6eaefcdd21e3fe2fd0 | SER-b10920b0938006936416e77746fca29eebebcff6e86f9c3350f5df2ba56b3106 | Suppressed by Open Order | **** | **** | **** | Harbor Pathology Labs, LLC | 43193 | Vendor | Philadelphia | PA | Northeast | Unknown | Medium | Greiner Bio-One | — | — | — | — | — | Analyzer Platform Purchasing Loss; 6 independent signals; trailing 90-day revenue $2063.87 versus $2665.66; trailing 180-day revenue $4729.53 versus $17581.33; 12 days beyond expected account order date. | 3212.95 | 6425.9 | 9638.85 | 892.74 | 1785.47 | 2678.21 | 84.47 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-c4a42b6740cc1541f51908edf4b19e8e81ff8f16a5a0c5d6041c738da0684406 | Customer 43193 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7a3376188eeda2c8288be87307674d6ccb3c0844f437b27890a30861ce2e8c67 | OPP-a3ae05db50f4dfb16529584a3f0e5413a50530415a42449b845a28e6aa6b8ab2 | SER-499de8edab9aadedca3162e090e04f91dcc39a110062efb2ce9a19c0428a23af | Needs Validation | **** | **** | **** | Meridian Reference Labs, Inc. | 8324 | HQ | Keyport | NJ | Northeast | Unknown | Medium | Bio-Rad | — | — | — | — | — | Analyzer Platform Purchasing Loss; 5 independent signals; trailing 90-day revenue $6131.14 versus $0.00; trailing 180-day revenue $6131.14 versus $15516.70; 27 days beyond expected account order date. | 2346.39 | 4692.78 | 7039.17 | 1051.2 | 2102.41 | 3153.61 | 83.36 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-7a3376188eeda2c8288be87307674d6ccb3c0844f437b27890a30861ce2e8c67 | Customer 8324 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b9d4d8abd4b62f7c88c34d93f49f5e57072d533651156797ba5dccee4c31eb31 | OPP-79f4756e7f183c5c552545505a268a821d289329773e173304fcb9f47515a58b | SER-c88ffb1a9a09373d7581c1039661c1eb5857fdae20b2fd2a615bb1289792d07c | Suppressed by Open Order | **** | **** | **** | Silverline Clinical Group, Inc. | 8342 | HQ | Edison | NJ | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Reduced Order Frequency; 2 independent signals; trailing 90-day revenue $38238.00 versus $56803.00; trailing 180-day revenue $95041.00 versus $76223.05; 4 days beyond expected account order date. | 9282.5 | 18565.01 | 27847.51 | 3558.34 | 7116.68 | 10675.03 | 82.04 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-b9d4d8abd4b62f7c88c34d93f49f5e57072d533651156797ba5dccee4c31eb31 | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78ecb2d2569dad09476f575202c1e99386f3561afb08929313a3dd58dfd762b4 | OPP-5422b5772e493bdb7e7de3a09f12cf69462180937766ec74ee8703f88e8e8d88 | SER-d6c5036545239c0fa68517b4d15edad2173fe7024e80c932a82cc31fee4c9d78 | Needs Validation | **** | **** | **** | Northgate Health System, Corp. | 7771 | HQ | Patchogue | NY | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 384 days beyond expected account order date. | 13582.9 | 27165.79 | 40748.69 | 9212.79 | 18425.59 | 27638.38 | 81.84 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-78ecb2d2569dad09476f575202c1e99386f3561afb08929313a3dd58dfd762b4 | Customer 7771 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8cfd273aa666779a3528c51047734884157637fc372a3f6a08c7241c4d6bfbff | OPP-ce9dd30192b5388a60e161ac6fe39e6a350b29eb7cb20f05503b48f0402f51ce | SER-844e76fa0d3f647814538fe193dd59611a6ea1c6e97baf752e1a132aa4de6ab2 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | — | Parts Group | — | — | — | — | Product Family Purchasing Loss; 5 independent signals; trailing 90-day revenue $3822.19 versus $9135.32; trailing 180-day revenue $12957.51 versus $23346.55; 7 days beyond expected account order date. | 2656.57 | 5313.13 | 7969.7 | 674.86 | 1349.72 | 2024.58 | 80.33 | High | False | True | — | CALL | Candidate CAND-8cfd273aa666779a3528c51047734884157637fc372a3f6a08c7241c4d6bfbff | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-66c3a89df4edd43c336c4a16451962b2c615f454eb065a125aa1491b08c2235c | OPP-a97460db2218dc60f374f2cc0b036b23cc9ae6bb7233a6521f77342108a5928b | SER-ac9b82f1b5ffdaffd1e99a553d724b4eec3df39601d655efcfa5eba4853cde5c | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 2 independent signals; trailing 90-day revenue $11563.03 versus $13914.16; trailing 180-day revenue $25477.19 versus $55643.04; -3 days beyond expected account order date. | 7541.46 | 15082.92 | 22624.39 | 5495.3 | 10990.61 | 16485.91 | 79.81 | High | False | True | — | CALL | Candidate CAND-66c3a89df4edd43c336c4a16451962b2c615f454eb065a125aa1491b08c2235c | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-99ff3259cc2055a588be8b724b1cd35b8edd977144dd97906f31ec030d6a9301 | OPP-7fb482d7c29c6700183ad7bde30ba4a7aff9808aae3629eec4406f84da17d59b | SER-018d98cfd22e89b5cbe5a4ce09df84b71711682d8769e36b6247a101ebee2e43 | Needs Validation | **** | **** | **** | Summit Analytical Labs, PLLC | 8970 | HQ | Woodbury | NY | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 657 days beyond expected account order date. | 6295.24 | 12590.48 | 18885.72 | 4022.95 | 8045.89 | 12068.84 | 79.52 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-99ff3259cc2055a588be8b724b1cd35b8edd977144dd97906f31ec030d6a9301 | Customer 8970 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-360f57a10849f652a0465f1b3670c2e11f935f76dc548ae58f12768f880e07db | OPP-54b37807168ad3b601f5f755815904d8af4a40659224bb5fffe507dfa4797a11 | SER-b6cb11950e937c98f14f4efe24cf109e2a33ed6c57f3b86e887fb23be366e31c | Published | **** | **** | H | Lakeside Laboratory Partners, LLC | 6566 | HQ | Somerset | NJ | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 4 independent signals; trailing 90-day revenue $0.00 versus $3521.00; trailing 180-day revenue $3521.00 versus $1688.78; 96 days beyond expected account order date. | 1760.5 | 3521 | 5281.5 | 846.5 | 1693.01 | 2539.51 | 78.03 | High | False | True | — | ENRICH_CONTACT | Candidate CAND-360f57a10849f652a0465f1b3670c2e11f935f76dc548ae58f12768f880e07db | Customer 6566 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8fd26819d8d566530e13983efac25ac59004c971d9f4fefa3754ab962c517a6d | OPP-11dacbabf13b094d8fb27c42e55a829b0e82fa4d8e40bdafc68a3567d9061b16 | SER-3ac81e7088ff67fe7385bb7d50c0c6b88a7f9a120b072da553a247d38d970bad | Published | **** | **** | **** | Bellwood Diagnostic Labs, Inc. | 6759 | Vendor | Devens | MA | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 458 days beyond expected account order date. | 5401 | 10802 | 16203 | 2686.41 | 5372.83 | 8059.24 | 75.53 | Medium | False | False | — | CALL | Candidate CAND-8fd26819d8d566530e13983efac25ac59004c971d9f4fefa3754ab962c517a6d | Customer 6759 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ab4f1d3b83a5f1be455bb4819ea86f320bb88e41c9dae7ec679a35436d3201c4 | OPP-d751f0e8db204853bc303b9a9cc5902cfd1f2e379968822c70f2d1386a8c0896 | SER-7fb4928a09cab62b71b80e7783e8ae89a762ef1fb0ee8a19b86870906c629fc4 | Needs Validation | **** | **** | **** | Bridgeport Diagnostics, Corp. | 5592 | HQ | Brooklyn | NY | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $5397.15 versus $4146.58; trailing 180-day revenue $9543.73 versus $10219.05; -30 days beyond expected account order date. | 3474.07 | 6948.14 | 10422.21 | 2775.25 | 5550.49 | 8325.74 | 74.18 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-ab4f1d3b83a5f1be455bb4819ea86f320bb88e41c9dae7ec679a35436d3201c4 | Customer 5592 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-24058a69041f0b6a163b8e512968f5c6fb4663eb9d81fbd66d811a2769683701 | OPP-857e538fb6add0aeb75a4d489dfa810b0351492b52b44daa5a241c214d1f428b | SER-0e8abff944c0566e77ac1aadfb6f362042f52ad455fe9cba529683d8f5936fde | Published | **** | **** | **** | Silverline Clinical Group, Inc. | 8342 | Vendor | Edison | NJ | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Materially Delayed Purchasing; 3 independent signals; trailing 90-day revenue $0.00 versus $1051.00; trailing 180-day revenue $1051.00 versus $1527.51; 118 days beyond expected account order date. | 525.5 | 1051 | 1576.5 | 136.42 | 272.83 | 409.25 | 70.55 | Medium | False | True | — | CALL | Candidate CAND-24058a69041f0b6a163b8e512968f5c6fb4663eb9d81fbd66d811a2769683701 | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a7f7be298793cc4479ebb7642d25b881b6bd8152cf47b6ee1110ddbbc57b37e4 | OPP-18b22fbe5c8bb7459503398c4a57e875c6722647f0fd0779796a1a8ceee0daa4 | SER-24dec4158ad0b0df19fadf8af715aea93c099a794d89076654bf2c8a789be930 | Needs Validation | **** | **** | **** | Elmhurst Physician Group, Inc. | 9102 | HQ | Philadelphia | PA | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 370 days beyond expected account order date. | 2197.25 | 4394.51 | 6591.76 | 698.74 | 1397.49 | 2096.23 | 69.82 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-a7f7be298793cc4479ebb7642d25b881b6bd8152cf47b6ee1110ddbbc57b37e4 | Customer 9102 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bdbcb529e59175cade218d43af2e53a15ffc8746af12fc71b51151151f12612c | OPP-3585fc6abd5d4fc0341d3a94a3cb09f86087db0a2835811cbec02c8c10d80bd3 | SER-01ed01469f539f27819a39ab901e2d538ef5bbcabb81b8edce4c400fc581cc60 | Published | **** | **** | **** | Summit Health System, Inc. | 5175 | HQ | Jamaica | NY | Northeast | Distributor | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $330.00; trailing 180-day revenue $330.00 versus $0.00; -17 days beyond expected account order date. | 2352.38 | 4704.75 | 7057.13 | 880.19 | 1760.38 | 2640.57 | 68.88 | Medium | False | False | — | CALL | Candidate CAND-bdbcb529e59175cade218d43af2e53a15ffc8746af12fc71b51151151f12612c | Customer 5175 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ccb891daa7ded4cd6f54e28afec9c3d5156b635e7d9c579778d44fc3fbe50a71 | OPP-625d97027c977afa3f6548fd7bba17057f813631930e74b4b4ea9b76d7d6c621 | SER-538233def0009743a276428324f049baeede57a32ce77abd6544f2ea47cdf41c | Needs Validation | **** | **** | **** | Whitmore Lab Services, Inc. | 6421 | Vendor | North Quincy | MA | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $1186.05; trailing 180-day revenue $1186.05 versus $4644.45; -53 days beyond expected account order date. | 864.6 | 1729.2 | 2593.8 | 229.29 | 458.58 | 687.88 | 67.59 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-ccb891daa7ded4cd6f54e28afec9c3d5156b635e7d9c579778d44fc3fbe50a71 | Customer 6421 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | OPP-50cedd9a3e3f93e3517182b814a35224adeec1c0cdd938886c898a875c531157 | SER-fc3b62d3d430662f48d3cd5ac8b6e63a72685cd4482b93bd6e9315b8cf9f57a6 | Needs Validation | **** | **** | **** | Whitmore Pathology Associates, Inc. | 5440 | HQ | Brooklyn | NY | Northeast | Unknown | Medium | Beckman Access / DxI | — | — | — | — | — | Analyzer Platform Purchasing Loss; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1481.60; 318 days beyond expected account order date. | 377.32 | 754.63 | 1131.95 | 280.19 | 560.38 | 840.57 | 66.14 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | Customer 5440 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cbcb9c27432db82eb871efdace2faaabcdfb557c414e13f68ee8e3250ca498e9 | OPP-74c9f7e5cf07e833bc8c894de00a8232dc596f7eb0a90442516c54854c523498 | SER-4cc6f0aa3e04b5556071d2280bb709ed7bd2acb8123c9cc5655c0654eb1be6c8 | Needs Validation | **** | **** | **** | Meridian Diagnostics, Corp. | 9178 | Vendor | Monmouth Junction | NJ | Northeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 406 days beyond expected account order date. | 1902.21 | 3804.42 | 5706.62 | 658.15 | 1316.31 | 1974.46 | 65.75 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-cbcb9c27432db82eb871efdace2faaabcdfb557c414e13f68ee8e3250ca498e9 | Customer 9178 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9cc6089cc1cf33e045c24724cd4c3ba1dd60eeea019d29d200233e02c3e83a8c | OPP-7d4ffa153599fc7836f2c53f08814b96ae8ab3cc8ff8634fa399f80073d807d7 | SER-f3211059db97572d3e479ef25de5988213bc9028546b582b1b33d1575851af98 | Needs Validation | **** | **** | **** | Ashcroft Medical Center, Corp. | 605 | HQ | Bohemia | NY | Northeast | Unknown | Medium | — | — | — | — | — | — | Reduced Order Frequency; 2 independent signals; trailing 90-day revenue $4580.83 versus $5067.28; trailing 180-day revenue $9648.11 versus $14523.33; -17 days beyond expected account order date. | 1218.81 | 2437.61 | 3656.42 | 599.41 | 1198.82 | 1798.23 | 64.96 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-9cc6089cc1cf33e045c24724cd4c3ba1dd60eeea019d29d200233e02c3e83a8c | Customer 605 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4a3e115566ab7f804a62c703c6b2abcb41b370b9998b9cc772d09547377beccc | OPP-02bdb580e5322d10c93ea3c813b846296a7af0bd2c3d83b66e986f3fc3d60cf5 | SER-cf19692a2afb41eaf85d18a1d1036bd833db20c512ce7855a7316dccb4646241 | Suppressed by Counter-Evidence | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | University Place | WA | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $0.00 versus $2044.84; trailing 180-day revenue $2044.84 versus $1547.97; 79 days beyond expected account order date. | 1022.42 | 2044.84 | 3067.26 | — | — | — | 64.39 | Low | False | False | — | SUPPRESS | Candidate CAND-4a3e115566ab7f804a62c703c6b2abcb41b370b9998b9cc772d09547377beccc | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b9d02a84e634f25c0496223e7a2f13899374f0cfdf60267afd1eb944f1bdfb7d | OPP-7b6334f81ec590ea5aed212c4710a8c12a099dce14ba6174715b42a542d09b5b | SER-3859ee5eb301d0375ae25f7b08a96ba5f6d85621b18e75f6d86be25e5ebeced7 | Needs Validation | **** | **** | **** | Ironwood Diagnostic Group, Corp. | 10240 | Vendor | Union | NJ | Northeast | Research Institution Operating Instruments | High | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $823.39; trailing 180-day revenue $823.39 versus $3652.45; 70 days beyond expected account order date. | 707.27 | 1414.53 | 2121.8 | 193.48 | 386.95 | 580.43 | 61.42 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-b9d02a84e634f25c0496223e7a2f13899374f0cfdf60267afd1eb944f1bdfb7d | Customer 10240 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-81d0008fe8f1d75f4eee383ee838d7ad84d173b603592bb05e147c625e74c6f3 | OPP-f80cfcd83d86313909ffed0ed0b59c73d2c174e6071cc32322ea871dbe444007 | SER-15069a64aa5bd2bc0b6825d7b626c1a8c5c485b4c5eeed510c1f0951504e1a1c | Needs Validation | **** | **** | **** | Maple Clinical Partners, LLC | 5261 | HQ | Garden City | NY | Northeast | Unknown | Medium | — | Beckman Access | — | — | — | — | Product Family Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $942.30; 318 days beyond expected account order date. | 362.83 | 725.66 | 1088.5 | 244.13 | 488.25 | 732.38 | 61.24 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-81d0008fe8f1d75f4eee383ee838d7ad84d173b603592bb05e147c625e74c6f3 | Customer 5261 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fd5f7f4646848cb1f2df5de17eeb95c81e060d2d77ac052079542c3069b24643 | OPP-8fba159542a9e0c668e0cfedd98b07603b55651959f9b33ffc415ab716161d1c | SER-cb12dd714c8c63b178cdafc485480ebe07d2ca6d6b59a84ffbea5a72b76fcf91 | Suppressed by Open Order | **** | **** | **** | Bridgeport Lab Services, Corp. | 5688 | HQ | Salem | NH | Northeast | Unknown | Low | — | Siemens | — | — | — | — | Product Family Purchasing Loss; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1727.92; 150 days beyond expected account order date. | 431.98 | 863.96 | 1295.94 | 130.39 | 260.78 | 391.17 | 57.12 | Low | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-fd5f7f4646848cb1f2df5de17eeb95c81e060d2d77ac052079542c3069b24643 | Customer 5688 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | OPP-dede2f1d8cd9e203b014fcaa926ed5854997e34ae629e8798dddebaeec1ef576 | SER-a966b3fa27cea4d9f0bb3e2bf1409fba3d9504eee8507b2e36a2b3f1f22e172d | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | University Place | WA | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $885.73; trailing 180-day revenue $885.73 versus $1435.58; 62 days beyond expected account order date. | 529.95 | 1059.9 | 1589.85 | 129.15 | 258.3 | 387.44 | 56.42 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8784a0b79f79ca246007f58644b836a159b6ceee0fee3a4f18e1adf68cd87e06 | OPP-09c1c324cf75a2c0f72d734f0e4ccf7fd6ec0778aa4e4c3c3a52197a7abc5e79 | SER-e09a6d4c47fdc2e3d07d228004260fb7b518e6f6276c4c691dc09b8a58abf937 | Needs Validation | **** | **** | **** | Stonebridge Health System, PLLC | 44486 | HQ | Olympia | WA | Northeast | Reseller | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $4597.76 versus $3899.85; trailing 180-day revenue $8497.61 versus $14939.22; 26 days beyond expected account order date. | 1610.4 | 3220.81 | 4831.21 | — | — | — | 55.3 | Medium | False | True | — | MANAGER_REVIEW | Candidate CAND-8784a0b79f79ca246007f58644b836a159b6ceee0fee3a4f18e1adf68cd87e06 | Customer 44486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | OPP-e1066fe70160427f60bb9294097792fbef9313eace35690f4cdff655b10df898 | SER-c3b907c33a8cbef2256f877f1cf45adc889807748f1d4cb7c0d0f772ed242aba | Needs Validation | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $4069.59 versus $3422.73; trailing 180-day revenue $7492.32 versus $9881.05; -19 days beyond expected account order date. | 617.49 | 1234.98 | 1852.47 | 295.76 | 591.53 | 887.29 | 52.55 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | Customer 7389 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d82dbe8f82092324328feb79a967cc66faa6c22ef8836efe7bb245b57ffe0989 | OPP-551f59826e52bef94bb01aa95e54b0693e732c3c9ae2610bf778350a6b5a8e74 | SER-524ef9a3d21d1b6e4598ea82032ea8114121f950f1cf8227ff0703385cdc0127 | Needs Validation | **** | **** | **** | Silverline Clinical Group, Corp. | 42652 | Vendor | North Andover | MA | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $682.95; trailing 180-day revenue $682.95 versus $741.64; 23 days beyond expected account order date. | 341.48 | 682.95 | 1024.43 | — | — | — | 48.72 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-d82dbe8f82092324328feb79a967cc66faa6c22ef8836efe7bb245b57ffe0989 | Customer 42652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6b9b4b4a813277b30b1c1826271dbd2c7c85e8a80ed8f7cc65a69e1729ec6a5a | OPP-507dd039be0ba1514cae3c26a7a2d1ee96779adc65868fd45ed83d6241ac42a8 | SER-ab23a3a6e0bc5f0626337ed457812f971f1c7ceb38acb674b7a8a25cad81eec8 | Needs Rep Mapping | Unassigned / Needs Mapping | — | **** | Copperfield Reference Labs, Corp. | 16404 | Myco | Laredo | CP | — | End-User Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $20682.51; trailing 180-day revenue $20682.51 versus $44301.50; 103 days beyond expected account order date. | 10341.26 | 20682.51 | 31023.77 | 3070.19 | 6140.38 | 9210.58 | 88.65 | High | False | False | — | CALL | Candidate CAND-6b9b4b4a813277b30b1c1826271dbd2c7c85e8a80ed8f7cc65a69e1729ec6a5a | Customer 16404 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e16a41014de3fa8f46d19908a137b52f8438a33fbfaa3659a30a5bba98308498 | OPP-1159c6e4a846ca62ff10251f4a7eaea521fe565523a306fb8666b1e925c32cae | SER-01e3d4550351d7a1fb47f3cc66526aa021540b762ad0fd2deb41390a99bcc5dd | Suppressed by Open Order | Unassigned / Needs Mapping | — | **** | Meridian Laboratory Partners, PLLC | 8652 | HQ | Erith | — | — | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $3760.00 versus $13357.74; trailing 180-day revenue $17117.74 versus $46267.12; 9 days beyond expected account order date. | 7287.35 | 14574.69 | 21862.04 | 1249.31 | 2498.63 | 3747.94 | 86.49 | Medium | True | True | Open Order | MANAGER_REVIEW | Candidate CAND-e16a41014de3fa8f46d19908a137b52f8438a33fbfaa3659a30a5bba98308498 | Customer 8652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a0a84692fe5bf10ca6a3f11dcfbfc389823e1407582788bbca60582ca35b5ab1 | OPP-91fd94be840beff93528b517ca6a05814d6bb3ebd21aedd00385cf7791135b45 | SER-79dff804aaa80365aa63b1281907b73cd19ab1fb1546b288c3d545507b2e9cb2 | Needs Rep Mapping | Unassigned / Needs Mapping | — | **** | Copperfield Reference Labs, Corp. | 16404 | HQ | Delegacion Benito Juarez | CP | — | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 423 days beyond expected account order date. | 11762.31 | 23524.61 | 35286.92 | 6130.38 | 12260.76 | 18391.14 | 75.8 | Medium | False | False | — | CALL | Candidate CAND-a0a84692fe5bf10ca6a3f11dcfbfc389823e1407582788bbca60582ca35b5ab1 | Customer 16404 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c4013b75f611e3a10ae1aa9d29af990e49fac03903ee78a419adbd23f099c700 | OPP-f66d6b46911c7a4c069b7a2087494892a18b95e8d06772b21ed914887f7b98e6 | SER-fcdeb52a4772eed7924d82e9e258291e7e89ae1919fafe02abba8a0b1914e226 | Needs Rep Mapping | Unassigned / Needs Mapping | — | **** | Northgate Analytical Labs, PLLC | 8699 | Vendor | Tamuning | — | — | End-User Laboratory | High | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $27080.68 versus $0.00; trailing 180-day revenue $27080.68 versus $0.00; -6 days beyond expected account order date. | 15519.43 | 31038.87 | 46558.3 | 10136.33 | 20272.65 | 30408.98 | 69.32 | Medium | False | False | — | CALL | Candidate CAND-c4013b75f611e3a10ae1aa9d29af990e49fac03903ee78a419adbd23f099c700 | Customer 8699 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c689b37ee5732df3c091344f3dfe8eaf577e7d81900a96716213416aee10cde6 | OPP-0d54620bb6dc1660d4d30ab5d30b9e15d789194acbff55a1de5558acb9526d8d | SER-2236017470be4282400362ee9e9842b87e11064f0c79f836ddef5ea02ac94c61 | Needs Rep Mapping | Unassigned / Needs Mapping | — | H | Bridgeport Pathology Associates, Inc. | 5985 | HQ | Sabana Seca | — | — | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1456.44 versus $3460.08; trailing 180-day revenue $4916.52 versus $3402.26; 9 days beyond expected account order date. | 1001.82 | 2003.64 | 3005.46 | 287.12 | 574.24 | 861.35 | 57.42 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-c689b37ee5732df3c091344f3dfe8eaf577e7d81900a96716213416aee10cde6 | Customer 5985 |